Engrailed genes are cell autonomously required for the survival of the mesencephalic dopaminergic neurons by Alberi, Lavinia
DISSERTATION
submitted to the
Combined Faculties for Natural Sciences and for Mathemathics
of the Ruperto-Carola  University of Heidelberg, Germany
for the degree
of Doctor of Natural Sciences
Presented by
Lavinia Alberi
born in Trieste 24.07.1974
2004
ENGRAILED GENES ARE CELL AUTONOMOUSLY
REQUIRED FOR THE SURVIVAL OF THE MESENCEPHALIC
DOPAMINERGIC NEURONS
Referees: Prof. Dr. Beyreuther
Prof. Dr. Witzemann
"gnoqi s’ autón"
Âokraths
TABLE OF CONTENTS
ACKNOWLEDGMENTS........................................................................................I
ABBREVIATIONS ................................................................................................ II
SUMMARY .............................................................................................................V
INTRODUCTION................................................................................................... 1
1. General introduction................................................................................................................................. 2
2. The dopaminergic system......................................................................................................................... 3
2-1. Location of the midbrain DA neurons in the rodent brain ................................................................ 3
2-2. The dopaminergic afferent projections to the striatum ..................................................................... 4
2-3. The afferent projection to the mDA neurons..................................................................................... 5
2-4. Function of the midbrain DA system................................................................................................. 6
3. Parkinson’s disease ................................................................................................................................... 7
3-1. Epidemiology and Clinical traits........................................................................................................ 7
3-2. Causes and pathogenesis of PD.......................................................................................................... 8
3-3. Mechanisms of cell death in the nervous system .............................................................................. 9
3-4. Apoptosis and Parkinson Disease .................................................................................................... 10
3-5. Key molecules in neuronal apoptosis............................................................................................... 11
3-6. Molecular pathways for neuronal cell death in PD ......................................................................... 14
3-7.  Models for Parkinson disease MPTP, 6-OHDA, and Rotenone.................................................... 17
3-8. Targeting apoptosis in Parkinson disease ........................................................................................ 19
3-9. Clinical treatment of PD................................................................................................................... 20
4. Development of the midbrain DA neurons .......................................................................................... 21
4-1. Midbrain patterning and specification ............................................................................................. 21
4-2. Induction of the midbrain dopaminergic neurons............................................................................ 22
4-3. The maturation phase........................................................................................................................ 25
4-3-I. Extracellular factors ....................................................................................................................... 25
4-3-II. Intracellular mediator ................................................................................................................... 25
Nurr-1 ....................................................................................................................................................... 26
Lmx-1b ...................................................................................................................................................... 27
Ptx-3.......................................................................................................................................................... 28
Engrailed-1 and 2..................................................................................................................................... 28
4-4. The dopaminergic phenotype ........................................................................................................... 29
4-4. The dopaminergic phenotype ........................................................................................................... 30
MATERIALS AND METHODS .......................................................................... 32
1. Generation and maintenance of mice ................................................................................................... 33
2.  Genomic DNA extraction ...................................................................................................................... 33
3. Derivation of En-1-/- En2-/- stem cells ................................................................................................. 34
3-1. Preparation of feeder layer cells from mouse embryonic fibrobloblasts........................................ 34
3-2. Mytomicin C treatment of fibroblast feeder cells............................................................................ 34
3-3. De novo isolation of embryonic stem cells from E3.5 blastocysts ................................................. 35
4. Immunohistochemistry........................................................................................................................... 36
4-1. Processing of the embryonic specimen............................................................................................ 36
4-2. Processing of the whole mounts....................................................................................................... 36
4-3. Immunohistochemistry ....................................................................................................................... 36
5. In situ Hybridization............................................................................................................................... 37
5-1. Synthesis of mouse En-1 riboprobe ................................................................................................. 37
5-2. In situ hybridization with mouse En-1 riboprobe............................................................................ 38
6. BrdU labeling........................................................................................................................................... 39
7. Coverslip coating..................................................................................................................................... 39
8. Threedimensional collagen gels from rat tails..................................................................................... 40
9. Primary cell culture ................................................................................................................................ 40
10.  Neurointoxication................................................................................................................................. 41
11. RNA interference in vitro..................................................................................................................... 41
11-1. siRNA design.................................................................................................................................. 41
11-2. siRNA transfection ......................................................................................................................... 42
12. Caspase inhibition................................................................................................................................. 42
13. Real time PCR on E12.5 and E14.5 ventral midbrain tissue........................................................... 43
13-1. RNA isolation ................................................................................................................................. 43
13-2. Reverse transcription ...................................................................................................................... 43
13-3. Real time PCR ................................................................................................................................ 44
14. Promoter analysis.................................................................................................................................. 45
15. Retroviral construction and infection ................................................................................................ 45
16. Image processing ................................................................................................................................... 46
RESULTS .............................................................................................................. 47
1. Cell autonomous requirement of En1/2 in the midbrain DA neurons............................................. 48
1-1. The midbrain DA neurons are induced in the En-1/2-/-, but fail to survive................................... 48
1-2. Developmental expression of Engrailed in the mDA neurons ....................................................... 50
1-3. The demise of the midbrain dopaminergic neurons occurs by apoptosis....................................... 51
2.  Axonal outgrowth of the mDA neurons in En-1-/-, En-2-/- mice..................................................... 52
2-1. Engrailed does not regulate axonal outgrowth of the mDA neurons.............................................. 52
2-2. L1 expression is not under Engrailed regulation............................................................................. 56
2-3. Differentiation of En-1-/-, En2-2- /- mDA neurons in vitro does not prevent these cell to die
by caspase-mediated apoptosis. ................................................................................................................. 57
3. Engrailed is not directly involved in triggering apoptosis ................................................................. 58
4. The midbrain DA neurons require En-1 and En-2 cell autonomously for their survival ............. 61
4-1.  En-1-/-, En-2- /- chimeric mouse .................................................................................................... 61
4-2. Chimeric En-1-/-, En-2- /- ventral midbrain culture ....................................................................... 62
5. RNA interference of En-1 leads to disappearance of the mDA neurons with En2-/- background
........................................................................................................................................................................ 65
6. Rescue of double mutant DA neurons by caspase inhibition ............................................................ 68
7. En-1 regulates p75 transcription........................................................................................................... 69
7-1. En-1 is transcriptionally repressing p75 expression........................................................................ 69
7-2. The p75(NTR) promoter contains consensus sequence for the homeodomain transcription factor
engrailed ................................................................................................................................................... 71
8.  En-1 overexpression in the chick.......................................................................................................... 72
DISCUSSION ........................................................................................................ 75
I. mDA neurons undergo apoptosis when ablated of En-1 and En-2 expression................................ 76
II. Engrailed does not regulate axonal outgrowth of mDA neurons..................................................... 78
III. mDA neurons require En-1 and En-2 cell autonomously for their survival ................................ 80
IV. En-1 RNAi induces rapid apoptosis of En-2 -/- mDA neurons ....................................................... 82
V. En-1 acts as repressor for p75NTR expression. ................................................................................. 84
VII. En-1 has no direct influence on dopaminergic progenitors........................................................... 86
Conclusions ................................................................................................................................................... 88
REFERENCES...................................................................................................... 90
IACKNOWLEDGMENTS
During these years of intense work and human exchange I experienced the joy of
doing research and for that I am particularly thankful to Dr. Horst Simon, who has
given me the chance to work in his lab and undertake such a fascinating project. I
learned from him to think scientifically, and strategically `More experiments at one
time the highest the chance of success´. I am also grateful to him for having thrilled
me, all the time, with new ideas and challenging discussion.
I am specially grateful to my colleague and friend, Paola, who is kind of a
"contagious" scientist and has been exciting me with her love and neck for science. I
should thank her for her dedication to each one of us in the lab, and I wish her a long
and successful scientifical career.
I would like to thank Danjel, my local citizen, who has actively taken part to lively
discussion in the lab, and has rescued me from the pitfalls of molecular biology. I
thank Christian and Lavinia Bhatt for having sustained me during these months of
intense writing.
I have to mention our wonderful technician Gabi, who is an extreme professional
worker and has always supported our work, providing each of us enormous help.
I eventually thank Jutta Fey, who has assisted me in the cell culture with useful tips
and knowhow.
II
ABBREVIATIONS
AADC l-Aromatic amino acid decarboxylase
AHD-2 Aldehyde dehydrogenase 2
AP Anterior-posterior
ATP Adenosine Triphosphate
BDNF Brain-derived neurotrophic factor
BME Basal medium eagle
BMP Bone morphogen protein
BrdU 5-Bromo-2´-deoxyuridine
CNS Central nervous system
COX Cicloxygenase
DA Dopamine
DAPI 4´,6-Diamidino-2-phenydole dilactate
DAT Dopamine transporter
D.i.v. Days in vitro
D.p.c Days post transfection
DNA Deoxyribonucleic acid
DMEM Dulbecco modified eagle medium
dNTP Desoxyribonucleotide
DV Dorsal-ventral
E Embryonic day
EDTA Ethylene diamine tetracetic acid
En Engrailed
En-1 Engrailed-1
En-2 Engrailed-2
FGF Fibroblast growth factor
FBS Fetal bovine serum
FP Floor plate
GABA g-aminobutyric acid
GP Globus pallidus
III
GDNF Glial cell line derived factor
HB Homogenization buffer
HH Hambuurger Hamilton stage
HS Horse serum
IL-1 Interleukin-1
INF-g Interferon gamma
L-15 Leibowitz medium-15
MAO Monoamine oxidase
MHB Mid-hindbrain boundary
MPDP+ 1-methyl-4-phenyl-2,3-dihydropyridinium
MPP+ 1-methyl-4-phenylpyridinium
MPTP 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
NCS New calf serum
NGF Nerve growth factor
NSC Neural stem cells
NT-3 Neurotrophin-3
6-OHDA 6-hydroxy dopamine
P75(NTR) Low affinity neurotrophin receptor p75
Park-1 Parkin-1
Park-2 Parkin-2
PCR Polymerase chain reaction
PBS Phosphate buffer saline
PD Parkinson disease
PFA Paraformaldehyde
PORN L-polyoornithine
RCAN Retroviral vector containing an acceptor null
RCAS Retroviral vector containing an acceptor sequence
RNA Ribonucleic acid
RRF Retrorubral field
RT Reverse transcriptase
Shh Sonic Hedgehog
Si Small interfering
SN Substantia nigra
IV
SNpc Substantia nigra compacta
Snpl Substantia nigra lateralis
Snpr Substantia nigra reticulata
SOD Superoxide dismutase
TH Tyrosine hydroxilase
TGF Transforming growth factor
TLZ Tau lac z
TNF Tumor necrosis factor
TNFR Tumor necrosis factor receptor
TUNEL Tdt-mediated dUTP nick end labelling
UTP Uracyl triphosphate
VMAT Vescucular monoamine transporter
VTA Ventral tegmental area
zVAD-fmk Benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone
-/- Homozygous for null mutation of the gene of interest
-/+ Heterozygous only one allele of the gene of interest is mutated
% Percentage
°C Celsius degree
g gram
hr hour
l liter
µ micro
M molar
ml milliliter
µl microliter
mm millimeter
µm micrometer
U unit
VSUMMARY
The dopaminergic neurons of the substantia nigra and ventral tegmentum are the main
source of dopamine in the central nervous system. The progressive loss of
dopaminergic neurons in the substantia nigra compacta over several decades leads to
one of the most prominent human neurodegenerative disorder, Parkinson´s Disease.
Accumulating evidence suggest that these neurons die by apoptosis in afflicted
patients. Still little is known about the molecular mechanisms that lead to full
differentiation and maintenance of these neurons. This neuronal population expresses
the homeobox transcription factors En-1 and En-2, briefly, after the cells become
postmitotic onwards. In mutant mice deficient for both genes, the neurons are induced
at the proper location, express TH, but at a time, when En expression sets in, these
neurons rapidly undergo apoptosis, so that at E14 the whole population is lost.
Another remarkable feature of those neurons is the lack of axonal projection towards
the telencephalon. We first addressed the question whether these neurons, lacking En,
were dying because of their inability to project and interact with trophic clues. In our
study we report that En genes are not regulating axonal outgrowth of mDA neurons,
and that these neurons if cultured onto permissive substrate elongate neurites of the
same length in comparison to the wild-type. Secondarily we addressed the question
whether the large deletion of midbrain tissue in En-1-/-, En-2-/- mutant embryos
deprives these cells of an essential trophic support released by the surrounding
neuroepithelium or whether the En genes are cell-autonomously required for the
survival of mDA neurons. To address this, we performed cell-mixing experiments of
En1/2 double mutant and wild type cells in primary cell culture of E12 ventral
midbrain and we observed that En-1-/-, En-2-/- mDA neurons, both in homotypic and
heterotypic cultures, are lost within 72 hours of culture. To complement these
experiments and verify whether the absence of any rescue effect of the mDA neurons
from the wild-type neuroepithelium was not a result of a pre-commitment to cell
death, at the time of dissociation, we silenced En-1 by RNAi in En-2-/- ventral
midbrain cultures. We observed, thereby, that in En-1 interfered cultures the number
of mDA neurons 4 days after transfection was always diminished about 25% and that
interfered En-1 mDA neurons rapidly undergo apoptosis. These results taken together
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demonstrate that En genes are cell-autonomously required for the survival and the
maturation of the dopaminergic neurons in the substantia nigra compacta and the
ventral tegmentum. Finally overexpression experiments in chick demonstrate that En-
1 is not involved in the specification of the dopaminergic precursors, since midbrain
tissue, transiently overexpressing En-1, did not show any increase in the number of
mDA neurons.  Our data suggest that genes downstream of En-1 and En-2 are
essential for the maturation and maintenance of this neuronal population and that
these transcription factors may be involved in Parkinson´s Disease.
2INTRODUCTION
21. General introduction
The midbrain dopaminergic neurons are the main source of dopamine in the
mammalian CNS. The catecholamine, dopamine, is a neurotransmitter responsible for
several neuronal functions, including motor integration, cognition (Backman and
Farde, 2001), attention (Nieoullon, 2002), emotion and reward (Schultz, 2001), as
well as sexual function (Giuliano and Allard, 2001).
The midbrain dopaminergic neurons are a relatively restricted population and are
divided into three distinct nuclei, the substantia nigra (SN), the ventral tegmental area
(VTA), and the retro rubral field (RRF)(Nelson et al., 1996). The nigral neurons
project to the dorsal striatum, and are innervated by different structures of the
diencephalon and telencephalon. The ascending nigrostriatal pathway regulates motor
control. The VTA neurons on the other hand, project to the limbic system and cortex
forming the mesolimbical pathways, which controls emotion and reward behavior
(Schultz, 2001). Alteration to this system are linked to schizophrenia, addictive
behavior and attention-deficit hyperactivity disorder (ADHD) (Watanabe et al., 1998;
Floresco et al., 2001).
The dopaminergic neurons are formed at stereotypic location in the ventral midbrain.
The induction and differentiation of the midbrain dopaminergic neurons is the result
of a various display of factors. Data arising from tissue transplantation and genetic
studies indicate that the mDA neurons are formed at the midbrain neural plate upon
the induction of two intersecting signals, the fibroblast growth factor-8 (FGF-8),
arising from the Mid-Hindbrain Boundary, and Sonic hedgehog (Shh), arising form
the floor plate (Ye et al., 1998). The inductive signal are believed to activate a
cascade of other signaling molecules and transcription factors such as Lmx-1b, Ptx-3,
Nurr-1, Engrailed-1 and –2 that finally lead to the full differentiation of this neuronal
population (Zetterstrom et al., 1996; Smidt et al., 2000; Simon et al., 2001; Hwang et
al., 2003).
Once the neurons have completed the last cell cycle and have become postmitotic,
they start to elongate their axons rostrally to reach their respective target; nigral
neurons project to the caudate putamen and tegmental neurons to the nucleus
accumbens, cortex, and olfactory tubercule.
3This neuronal population is heterogeneously affected during Parkinson disease, where
loss of dopaminergic neurons in the SNpc leads to the impairment of the nigral striatal
pathway, which results in bradikynesia, rigidity, resting tremor, and ataxia. The
disease can have genetic and/or environmental etiology. Different mechanism of cell
death have been proposed, necrotic (Kosel et al., 1997), apoptotic, and autophagic
(Anglade et al., 1997). Although still controversial recent evidence suggest the
apoptotic pathway as the principle mechanism responsible for the demise of this
neuronal population (Hartmann and Hirsch, 2001)
My Ph.D. project was focused on understanding the type of the requirement and role
of En-1 and En-2 for the midbrain dopaminergic neurons. As experimental mode I
used En-1 -/- En-2-/- mouse where the midbrain dopaminergic neurons are induced
but than shortly after disappear. I investigated the cell death time course both in vivo
and in vitro and unraveled the cell death mechanism leading to their disappearance.
2. The dopaminergic system
2-1. Location of the midbrain DA neurons in the rodent brain
The midbrain DA neurons are morphologically divided into three major cell groups
A9, A10 and A8. The area A9 identifies the substantia nigra (SN), which is further
subdivided in substantia nigra pars compacta (SNpc), substantia nigra pars reticulata
(SNpr), and substantia nigra pars lateralis (SNpl), the SNpc represent the main
dopaminergic subpopulation among the three. The area A10 indicates the ventral
tegmental area VTA, and the area A8 the RRF (Fig I.1).
The SNpc is densely packed with DA pyramidal-like neurons, whose dendrites invade
ventrolaterally the SNpr (Bjorklund and Lindvall, 1975) and there release dopamine
(Cheramy et al., 1981). More basal dendrites of the SNpc neurons, which spread
mediolaterally, invade overlying dorsal sheet of the SNpc and VTA. Another kind of
fusiform neurons is localized in the more dorsal aspect of the SNpc, and give rise to
dendrites, which protrude ventrolaterally into the SNpr. The neurons of the VTA are
characterized by a wide variety of shapes and sizes, 80% of the neurons are
dopaminergic the rest non-DA neuron (Halliday and Tork, 1986) at laterally
contiguous to the VTA, develops the SNpc. The cells from the two DA populations
have a very similar fusiform shape. Other DA neurons have radiating dendrites. More
4ventrally at the mid-anterior level the neurons are small and densely packed together
(Paxinos, 1985). The neurons of the RRF appear to be a caudal extension of the SNpc
and SNpl, are of middle size, and project to the striatum (Fallon and Moore, 1978).
2-2. The dopaminergic afferent projections to the striatum
The ventral and intermediate sheets of the SNpc and ventrolateral VTA give rise to
dopaminergic projections, which are directed towards the caudate putamen, and form
the nigrostriatal pathway. Whereas dorsal and middorsal VTA project to nucleus
accumbens and olfactory tubercule. VTA, lateral SNpc and SNpl in turn innervate the
amigdala. The lateral septum is innervated by ventral VTA, and adjacent-medial
SNpc. The neocortex receives the input from the dorsal-most sheet SNpc and VTA
neurons forming the mesocorticolimbical pathway (Fig I.2). Minor dopaminergic
projections are directed to the cerebellum, the hypothalamus, the raphe, the
hippocampus, the ventral pallidum and the locus coeruleus (Kizer et al., 1976; Fallon
and Moore, 1978; Simon et al., 1979; Gerfen et al., 1982; Swanson, 1982; McRae-
Degueurce and Milon, 1983; Gasbarri et al., 1991; Ikai et al., 1992; Prensa and
Parent, 2001).
Fig I.1 3D reconstruction
of the DA neurons in the
ventral midbrain. Caudal
to rostral (B-C). Group A8
in blue depicts the
RRF(B), group 9 in yellow
the SNC (C), and group 10
in red the VTA(D) From
German and Manaye 1993.
52-3. The afferent projection to the mDA neurons
 The g-aminobutyric acid (GABA)-ergic neurons of the striatal patch give rise to two
pathways that connect the striatum to the output nuclei of the basal ganglia, namely
the globus pallidus pars interna (Gpi) and the SNpr. Striatal projections from the
caudate putamen innervate the GPi and SNpr to form the direct inhibitory pathway.
Those striatal neurons bear Dopamine D1 receptor, coexpress substance P and
dynophorin and provide a direct inhibitory effect on their target. Striatal projection,
directed via subtalamic nucleus (STN) and globus pallidus pars externa (GPe) to the
GPi and SNpr, form the indirect inhibitory/excitatory pathway. These striatal neurons
can be recognized by differential expression of D2 dopamine receptor, Enkephalin.
Via their GABAergic output they inhibit the Gpe, activate the glutamatergic neurons
from the STN and thereby excite the GPi and SNpr (Fig I.3). Thus direct and indirect
pathways have antipodal effect on the dopaminergic target (Alexander and Crutcher,
1990) (Gerfen, 1992). Moreover afferent projection from the amigdala, hypothalamus,
preoptic area and cortex are directed t to the SNpc and VTA (Wright and Arbuthnott,
1980; Hurley et al., 1991; Wallace et al., 1992).
Fig I.2 Simplified
cartoon of  the
dopamine circuitory.
The SN and VT
p r o j e c t  t o  t h e
forebrain, the SN to
the Basal Ganglia and
the VT to the
Neocortex.
62-4. Function of the midbrain DA system
The midbrain dopaminergic neurons targeting a wide range of structure form a
complex network where any changes result in a dramatic alteration of many neuronal
functions.
The nigral neurons (SNpc) project to the caudate putamen forming the nigrostriatal
pathway, which indirectly controls voluntary motor movement by modulating the
striatal output neurons (Gerfen, 1992). The dorsal and middorsal VTA and medial
SNpc neurons innervate the nucleus accumbens and olfactory tubercule, whereas the
more ventral VTA and adjacent medial SNpc neurons project to the lateral septum
forming the limbic system, and eventually the dorsal-most sheet VTA neurons project
the neocortex to form the mesocorticolimbical pathway. The latter pathway together
with nigrostriatal pathway controls locomotor activity, mediates emotion, cognition,
Apathway, and as an
excitatory signal in the
direct pathway. (B) In
the parkinsonian state,
DA depletion leads to
d i s h i n i b i t i o n  o f
dopamine D2-receptor
on striatal neurons, in
the indirect pathway,
leading to increased
inhibition of the Gpe,
and dis-inhibition of the
STN. Overactivity in
the STN leads to excess
activation of the
n e u r o n s  i n  t h e
Gpi/SNpr and over-
inhibi t ion of  the
thalamo-cortical and
brain stream motor
centres resulting in
Parkinsonism.
Abbreviations PPN:
pedunculupontine
nuclei, SNC: substantia
nigra pars compacta,
VL: ventral lateralis
(Gerfen, 2000) .
Fig I.3 Schema of the afferent from and efferent projections to
the SNC. Representation of normal (A) and parkinsonian like (B)
dopaminergic circuitory. Blue arrows stems for inhibitory inputs and
red arrows for excitatory ones Thickness of the arrows indicates the
degree of activation of each projections. (A) The striatum
communicates with the output neurons in the globus pallidus pars
interna (Gpi) and substantia nigra pars reticulta (SNpr) through a
direct pathway, and with a synaptic connection in globus pallidus pars
Externa (Gpe) and the sub talamic nucleus (STn) through an indirect
pathway.  Dopamine acts threby as an inhibitory signal in the indirect
A B
STn
 Putamen
 SNC
GPe
GPi
SNr
PPN
               Cortex
VL
 Putamen
 SNC
GPe
STn
VL
GPi
SNr
PPN
PPN
N
               Cortex
7and memory processing (Le Moal and Simon, 1991).
Since different nuclei are involved in this system, a variety of functions is displayed.
Damage in this network to a specific neuronal subpopulation in this network will lead
to different symptoms, i.e. hyperactivaction of the mesolimbical pathway causes
abnormal behavior and schizophrenia (Jentsch et al., 2000; Floresco et al., 2001). In
turn progressive degeneration of the DA neurons of the SNpc results both in motor
and behavioral deficiencies, which are apparent in Parkinson’s disease.
3. Parkinson’s disease
3-1. Epidemiology and Clinical traits
Parkinson’s disease (PD) is a progressive neurodegenerative disorder, affecting 2% of
the population over 60 years of age (Elbaz et al., 2002) Positive family history
doubles the risk of developing PD to about 4%. Recent studies indicate that PD with a
early onset is more likely to be genetically related than PD cases with a late onset
(Tanner et al., 1999). Pathologically PD is characterized by a progressive loss of DA
neurons of the SNpc and ventrolateral VTA resulting in a deficiency of the striatal
and nigral dopamine. However due to a compensatory mechanism, such as
supersensitivity of DA receptor, bradikynesia and rigidity, are first encountered when
the dopamine concentration in the putamen is decreased to 75%, and when 60% of
nigral dopaminergic neurons are already been lost (Bernheimer et al., 1973). In
addition, the degeneration of dopaminergic neurons is associated with loss of
neuromelanin normally present in the human DA neurons (Kastner et al., 1992)
accompanied by strong glyosis (Folkerth and Durso, 1996). In PD, intracytoplasmatic
ubiquinated inclusion, called Lewy Bodies (LBs), are usually present in many of the
surviving neurons (Gibb and Lees, 1989). Lewy bodies are characterized by fibrillar
aggregates of a-synuclein, this molecular form of a-synuclein contrasts sharply with
normal a-synuclein, which is an abundant soluble presynaptic protein in brain
neurons (Dev et al., 2003). Nevertheless not all form of PD are characterized by the
presence of Lewy Bodies, brain of PD patients with autosomal recessive juvenile
parkinsonism (AR-JP), an early onset of PD, show only nigral degeneration but no
Lewy Bodies (Shimura et al., 2000).
The clinical symptoms result from the imbalances in the normal activity of the direct
8and indirect pathway. A decrease in striatal dopamine leads to an increase in
inhibitory GABA-ergic output activity in the basal ganglia, this increased output
coming from the basal ganglia conducts to an excessive inhibition leading to a
blackout of the thalamic and brainstream nuclei because of overinhibition by the
internal GP and SNpr through GABA. That causes a repression of the cortical motor
system, resulting in motor behavioral abnormalities, as bradikynesia, hypokinesia,
rigidity and tremor, and postural deficiency resulting from the inhibition of the brain
stem nuclei (Lang and Lozano, 1998; Hornykiewicz, 2001). PD patients suffer also
from autonomic dysfunction as dysautonomia including orthostatic hypotension,
gastrointestinal, urogenital, sudomotor and thermoregulatory dysfunction, pupillary
abnormalities and sleep and respiratory disorders (Micieli et al., 2003), psychiatric
symptoms as mood disorder and depression are also often diagnosed (Wolters, 2001).
3-2. Causes and pathogenesis of PD
 The specific etiology of Parkinson´s disease is not known. Epidemiological studies
indicate that the disease can have environmental and/or genetic origin. The
environmental hypothesis implies that neurodegeneration in PD results from the
exposure to neurotoxin affecting the dopaminergic system, and progression of the
neuronal degeneration may be produced by chronic neurotoxin exposure triggering a
perpetuating molecular cascade, which leads ultimately to cell death. Among the
environmental causes, the neurotoxin MPTP (1-methyl-4-phenyl-1,2,3,6-
tetrahydropyridine) is the best studied. The meperidine derivate induces parkinsonian
syndrome in humans with specific loss of the nigral dopaminergic neurons (Langston
et al., 1983).  In addition, exposure to other mitochondrial poisons such as the
pesticide, rotenone (McCormack et al., 2002), or herbicide, paraquat, increases the
risk of developing PD (Tanner, 1992). In addition, reactive oxygen species, generated
from the catabolism of DA, may generate a harmful oxidative stress and function as
endogenous neurotoxin for the mDA neurons. This would explain why long-term
consumption of L-DOPA in PD treatment results in a toxic oxidative effect for the
nigral remaining DA neurons (Soliman et al., 2002). The formation of free radicals
such as dopamine or hydrogen peroxide triggers a proteotoxic insult to the cells. This
eventually results in a-synuclein misfolding, ubiquitin and proteosome impairment
9and protein-aggregate formation, which are found in the typical LBs (Ostrerova-Golts
et al., 2000). Moreover products of oxyradicals are highly reactive species and leads
to oxidative damage resulting in abnormal lipid peroxydation in the substantia nigra
and widespread increase in protein and DNA oxidation can be detected in the brain of
Parkinson's disease patients (Jenner, 1998). In addition oxidative stress can lead to
mitochondria dysfunction related to reduced activity of complex I of the electron-
transport chain. Complex I impairment, in turn, leads to electron accumulation and
reduced ATP production which aggravate oxidative stress and results in apoptosis and
neuronal cell demise. Such mechanisms have been implicated in the pathogenesis of
both mitochondrial permeability transition pore-induced Parkinsonism and idiopathic
PD (Greenamyre et al., 1999). Moreover the inflammatory process, surrounding the
area of nigral loss in PD, leads to the release of proinflammatory cytokines, with
apoptogenic potential versus the surviving neurons, thereby perpetuating neuronal
degeneration and accelerating the progression of the disease (Hirsch et al., 2003). To
confirm the role of the contribution of the surrounding microglia in the progression of
the disease, it is reported that rotenone neurotoxicity is potentiated by the activation
of the surrounding neuroglia (Gao et al., 2002).
Recent studies have identifies genes, which are related to PD: Nurr-1 (Le et al., 2003),
parkin, a-synuclein, and most recently discovered but yet not fully unraveled UCHL-
1 (ubiquitin C-terminal hydrolase1)(Hoenicka et al., 2002). The three latter genes are
involved in the ubiquitin-proteosome pathway and that is of particular interest since
the LB aggregates are one of the pathological features of PD (Giasson and Lee, 2001;
Tanaka et al., 2001). Two missense mutation Ala53’  Thr and Ala30’Pro in a-
synuclein cause dominantly inherited PD (Polymeropoulos et al., 1997). Clinical and
pathological feature typical of PD have been found in patients with either mutation
(Kruger et al., 1998). Parkin was first discovered in patients with early PD onset.
Parkin related PD is characterized by the loss of SNpc but it is not associated with
LBs. Recent studies suggest that polymorphism at the parkin and synuclein loci may
contribute to the risk of idiopathic PD (Farrer et al., 2001).
3-3. Mechanisms of cell death in the nervous system
Neuronal cell death occurs through different mechanisms, which are distinguished as
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apoptosis, necrosis and autophagy. Apoptosis is the best understood mechanism for
neuronal cell death. It is characterized by cytoplasmatic condensation, nuclear
pyknosis, chromatin condensation, DNA fragmentation, cell rounding, membrane
blebbing, cytoskeletal collapse, and the formation of membrane bound apoptotic
bodies that are rapidly phagocytosed and digested by the neighboring scavenger cells.
Apoptosis has been observed during neuronal development, neural cell death caused
by acute injury such as ischemia and in neurodegenerative diseases such as
Parkinson´s disease, Alzheimer’s disease and Huntington’s disease and amyotrophic
lateral sclerosis (Yuan and Yankner, 2000). Necrosis is characterized by early
swelling of intracellular organelles followed by loss of plasma and nuclear membrane
integrity and finally cell edema. Necrosis is mostly associated with pathological
neuronal cell death following injury as in ischemia and stroke (Zheng et al., 2003). In
addition, certain developmental cell death exhibits feature of necrosis (Clarke, 1990).
Although apoptosis and necrosis are two different cell death mechanisms mediated by
distinct pathways, a mixture of the two or a transition from apoptosis to necrosis is
not a rare phenomenon (Moskowitz and Lo, 2003).
Autophagy is characterized by the appearance of cytoplasmatic autophagic vacuoles
of lysosomal origin, followed by mitochondrial dilatation and enlargement of the ER
and Golgi apparatus. Autophagy plays an important role in cellular homeostasis, and
in the turnover of intracellular organelles and proteins. This type of cell death has
been described in neurons during neuronal development (Xue et al., 1999) and in
association with degenerative disease such as Parkinson´s Disease (Anglade et al.,
1997).
3-4. Apoptosis and Parkinson Disease
Although still controversial, there are several reports of apoptosis as the principle
mechanism leading to the death of nigral DA neurons in PD (Olanow and Tatton,
1999; Andersen, 2001; Hartmann and Hirsch, 2001; Vila and Przedborski, 2003). The
feature of apoptosis implies nuclear DNA fragmentation caused by endonuclease
activation. This characteristic hallmark has been confirmed in studies on postmortem
brains of PD patients where five brains out of seven showed TUNEL positive DA
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neurons in SNpc (Mochizuki et al., 1996; Tompkins et al., 1997; Tatton et al., 1998).
The data was confirmed in rodents after treatment with sub-chronic doses of MPTP
(1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) (Tatton and Kish, 1997), a commonly
used for the human condition. More intriguingly, pro-apoptotic genes are upregulated
in nigral DA neurons of PD patients (Hartmann et al., 2001a) and the proportion of
neurons positive for activated caspase-3, a final effector of apoptosis (Green, 1998), is
five times higher than in healthy individuals (Hartmann et al., 2000). This suggests
that nigral DA neurons of PD patients are more susceptible to apoptosis than their
healthy counterparts. Furthermore, aggregates of a-synuclein, which are also found in
Lewy bodies of PD patients (Spillantini et al., 1997), promote apoptotic cell death in
cell culture (El-Agnaf et al., 1998). To conclude contradictory results on the apoptotic
origin of cell death in PD (Kosel et al., 1997; Banati et al., 1998) could be explained
by the relative low rate of cell loss in PD patients (McGeer et al., 1988), on the
contrary, the disappearance of apoptotic cell occurs in the range of only a couple of
hours (Raff et al., 1993). To further mitigate the discussion regarding the mode of cell
death in PD there is evidence that also other non-apoptotic forms of cell death take
part in the progression of PD (Sperandio et al., 2000).
3-5. Key molecules in neuronal apoptosis
Mammalian apoptosis is regulated by several key molecules i.e. the Bcl-2 family
proteins, the adaptor protein APAF-1, and the cysteine protease caspase family,
homologous of the C. elegans cell death gene product CED-9, CED-4 and CED-3
(Hengartner, 2000).
Neurons share the same basic of apoptosis program with all other cell types, however
distinct type of neurons, and neurons at different developmental stages express
different combination of Bcl-2 and caspase family members, suggesting a certain
specificity for apoptosis regulation (Yuan and Yankner, 2000). The Bcl-2 protein
family has a crucial role in intracellular apoptotic signal transduction. This protein
family include both proapoptotic and antiapoptotic proteins that have in common one
or more Bcl-2 homology domain (Merry and Korsmeyer, 1997).  The major anti-
apoptotic members of the Bcl-2 family, Bcl-2 and Bcl-xL are localized at the
mitochondrial outer membrane, endoplasmatic reticulum, and perinuclear membrane.
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Gain of function studies show that transgenic mice overexpressing Bcl-2 in the
nervous system are protected against neuronal cell death during development
(Martinou et al., 1994), and show increased resistance to MPTP (Yang et al., 1998)
and to 6-OHDA intoxication (Offen et al., 1998). In addition overexpression of Bcl-2
can rescue sympathetic neurons in case of neurotrophin withdrawal (Garcia et al.,
1992).
Bcl-xL, the other anti-apoptotic member of the Bcl-2 protein family, is continuously
expressed throughout adulthood (Gonzalez-Garcia et al., 1995). Bcl-xL-/- null mice
dye around E13 with massive cell death in the developing nervous system (Motoyama
et al., 1995). Bcl-xL may therefore be essential for the survival of immature neurons
before they have established any synaptic connection.
Bax is a pro-apoptotic member of the Bcl-2 protein family that is widely expressed in
the nervous system. Bax deficient mice have increased superior cervical ganglia and
facial nuclei. In the Bax-/- the midbrain dopaminergic neurons are more resistant to
MPTP intoxication (Vila et al., 2001) as well as neonatal sympathetic neurons and
facial motor neurons to neuronal cell death induced by NGF deprivation (Deckwerth
et al., 1996).
Downstream the Bcl-2 family member another essential molecule in apoptosis is
Cytochrome C, this molecule is released from the mitochondria to the cytosol where it
binds to Apaf-1 and caspase-9 and transmit the death signal from the mitochondria to
the effector caspases.
Apaf-1 is a mammalian homologue of C.elegans cell death gene product CED-4.
Apaf-1-/- mutant mice die during late embryonic development, they exhibit reduced
apoptosis in neural precursor, which leads to morphological defects as early as day
E9.5, and a marked enlargement of the periventricular proliferative zone (Cecconi et
al., 1998).
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Similarly to cytochrome c, Smac/Diablo and AIF are mitochondrial internal protein
responsible for activation of the apoptotic cascade. Once in the cytosol Smac/Diablo
interacts with several inhibitors of apoptosis (IAPs), which disinhibit apoptosis
initiators and effectors, respectively caspase-9 and caspase-3 (Chai et al., 2000; Du et
al., 2000), whereas AIF triggers cell death inducing directly chromatin condensation
and DNA fragmentation (Susin et al., 1999; Daugas et al., 2000).
The cysteine proteases, caspases, are the master players in apoptosis. Mammals have
14 different caspases, which are organized into parallel and sometimes overlapping
pathways that are triggered by different stimuli. Caspases are expressed as
catalytically inactive proenzymes composed of an amino-terminal pro-domain, upon
which they are classified, a large and a small subunit. Caspases with death-effector
domain, including casapase-8 and caspase-10, are activated by interaction with the
intracellular domains of the death receptors such as the CD95 (Apo-1/Fas), and tumor
necrosis factor (TNF) receptors. Caspases with short prodomains, such as caspase-3,
can be activated by most caspase pathways, whereas caspase-11, and 12 are activated
only under pathological conditions (Kang et al., 2000; Nakagawa et al., 2000). The
two major caspases involved in neuronal cell death are caspase-3 and –9. Both
homozygous null mice for caspase-3 (Kuida et al., 1996) and caspase-9 (Kuida et al.,
1998) mice show a similar defect in developmental neuronal cell death of progenitor
cells. Ectopic masses in the cerebral cortex, hippocampus, and striatum of the
Fig I.4 Scheme of  key molecules
involved in PCD. Both upon extracellular
or intracellular signals,  Bcl-x and Bax bind
to truncated Bid, t-Bid,the complex
translocate to the mitochondria where it
cause release of cytochrome c, Cyt C,
Inducing apoptotic factor, AIF, and second
mithochondrial activator caspase,
Smac/Diablo.Cytoplasmic CytC, binds to
Apaf-1 and recruits caspase-9, made
accessibile by the dishinibition of inihibitor
of apotosis,IAP. Caspase-9 can be
activated also from Caspase-12 under ER
stress. The molecular complex of
CytC/Apaf-1/Caspase-9 activates effector
caspases that lead finally to cell component
demise and cell death (Adapted and
modified from Vila et Prezdborski, 2003)
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caspase-3-/- and a marked expansion of the periventricular zone very much
resembling the phenotype of the Apaf-1 null mice. The prominent neuronal apoptosis
defect in all three mutant mice supports the requirement of neural progenitor cell
death in the normal neuronal development in vertebrate (Raff et al., 1993)
3-6. Molecular pathways for neuronal cell death in PD
Despite the recent evidence for the apoptotic nature of cell death in PD and PD
model, yet a mixture of necrotic and apoptotic cannot be excluded.
Apoptosis, called also programmed cell-death (PCD), is an active, genetically-
controlled, intrinsic program of cell "suicide" and it is characterized by morphological
hallmark as cell shrinkage and chromatin condensation (Ziv et al., 1997). Death by
Apoptosis results in a precise sequence of event:
I. An induction phase in which death can be stimulated by extracellular
or/and intracellular signals
II. An effector phase which translates the death inducing signals into the
ultimate decision to die
III. An end stage degradation phase in which morphological and biochemical
changes characteristic for apoptosis become apparent.
Apoptosis can be triggered via two different pathways: an external and an internal
cascade (Fig I.5).  Nevertheless both pathways can impair the function of the
mitochondria is believed to be a primary mediator of cell death in Parkinson´s disease
(Fiskum et al., 2003).
The death receptor or extrinsic apoptotic pathway is involved in the inflammatory
process that takes place during PD (Hirsch et al., 2003). This pathway is activated
upon binding of different cytokines such as INF-g, IL-1b, and TNF to cell surface
death receptors respectively Fas/CD95 or TNF receptor, moreover there is evidence
that p75 the low affinity neurotrophin receptor (p75NTR), bares a death domain
recalling the TNF receptor domain and it is able to induce cell death during
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development in sympathetic neurons (Frade et al., 1996), and of oligodendrocytes
upon NGF treatment (Casaccia-Bonnefil et al., 1996). Despite this similarities it
became recently clear that the molecular cascade signaling for p75NTR follows a
pathway, which differs from the TNF-cascade (Barrett, 2000; Dobrowsky and Carter,
2000; Troy et al., 2002). The binding of TNF or Fas ligand to their specific receptor
triggers activation of the intracellular “death domain”. This domain associates then
with an adaptor protein, containing a “death effector domain” respectively FADD for
Fas, and TRADD for TNF family receptors. These adaptor proteins recruit by
autoproteolytical activation caspase-8. This aspartic protease in turns cleaves, initiator
caspases, caspase-1, caspase-6, caspase-7, or the effector caspase-3, which ultimately
elicit the morphological hallmark of apoptosis. However caspase-8 can also mediate
translocation of BID, a proapoptotic member of Bcl-family, to the mitochondria and
the subsequent release of cytochrome c from mitochondrial intermembrane space into
the cytosol (Slee et al., 1999). Cytochrome c eventually triggers Caspase-3 activation.
Thus inflammation appears to be a feature of neurodegeneration with growing
pathogenic significance (Wyss-Coray and Mucke, 2002). Evidence for the
involvement of caspase-8 in PD arises from human postmortem study, and after
subchronical MPTP-treatment where a significantly high percentage of dopaminergic
(DA) of the SNpc neurons displayed caspase-8 activation (Hartmann et al., 2001b).
Several lines of evidence support that mitochondrial dysfunction contribute to the
Fig I.5 Signaling pathway that lead to
apoptosis in mammals.
The simplified cartoon shows the two
different pathways, the extrinsic and
intrinsic and their crosstalk. The extrinsic
cascade is activated upon formation of a
specific Death-Inducible- Signaling-
Complex (DISC), which activates caspase-
8, that can activate directly the effector
caspase-3 or cleave Bid, which in turn
induces translocation of Bax/Bak into the
mitochondrial outer membrane. The mito-
chondrial pathway is controlled by Bcl-2
family proteins, inhibitor of apoptosis or
caspases (IAP), and a second mitochondrial
activator of caspases (Smac).
(Adapted and modified from Orrenius et al,
2003)
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etiology of Parkinson´s disease (Schapira, 1999). It has been shown that genetic
mutations in the parkin gene on chromosome 6 in PD patients results in an
impairment of the electron chain transport I (Kosel et al., 1998). In addition sequence
analysis of the mitochondrial genome show that mitochondrial point mutations are
involved in PD pathogenesis (Vives-Bauza et al., 2002). One further line of evidence
comes from recent studies on cybrid lines, which contain a normal nuclear genome
but mitochondrial DNA form PD patients, and show a higher cytotoxicity to MPP+
(Swerdlow et al., 1996).
All these results indicate that the complex I defect in PD has a genetic cause and that
it may arise from mutations in the mitochondrial DNA. Studies on Parkinson etiology
report that disruption of the complex I can be induced by reactive oxygen species
(ROS), generated by a number of different systems through the action of monoamine
oxidase-B (MAO-B). As an example MAO-B is essential for i) the activation of 1-
methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to 1-methyl-4-pheny-2,3-
ldihydropyridinium (MPDP+) ii) for the enzymatic conversion of dopamine and 6-
OHDA to hydrogen peroxide (H2O2), and iii) for the activation of other potential
toxins such as isoquinolines and beta-carbolines  (Jenner and Olanow, 1996). It has
become clear overtime that the redox state of the mitochondria, namely the activity of
enzymatic reducer as glutathione, superoxid dismutase, and catalase, is extremely
important for the extent of mitochondrial injury. Inhibition of the mitochondrial
complex I represent the molecular basis for the MPP+, Rotenone, and 6-OHDA
neurotoxicity in the dopaminergic neurons, and thereby these substances are widely
used as neurotoxin in PD model (Feger et al., 2002). Studies on human PD
postmortem brains confirm this feature and report that inhibition of mitochondrial
alpha-KGDH and complex I, but not other respiratory complexes, is lower in the
parkinsonian SN (Shen et al., 2000). In addition recent studies show that production
of free radicals by mitochondria complex I can be activated by the sphingomyelin-
dependent transduction pathway. Convergent data from postmortem brain suggest that
this signaling pathway may be activated in the dopaminergic neurons disappearing
during Parkinson's Disease (France-Lanord et al., 1997).
Impairment of mitochondrial complex I induces the translocation of pro-apoptotic
molecules such as Bax to the mitochondria and leads to the release of mitochondrial
apoptotic protein including cytochrome c and apoptosis initiating factor (AIF) into the
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cytosol. Protein release from the mitochondria occurs either i) by physical disruption
of the mitochondrial outer membrane, due to osmotic swelling of the matrix caused
by accumulation of Ca2+in the mitochondria (Friberg and Wieloch, 2002), or ii) by
pore formation promoted by BH3/Bax/lipid interaction and which is directly inhibited
by Bcl-xL (Kuwana et al., 2002).
The endoplasmatic reticulum (ER) is the other organelle, which senses cell stress. It
may be also in the pathogenesis of PD. Bax and Bak are "multidomain" proapoptotic
proteins, which are also localized to the endoplasmic reticulum (ER). Similarly to the
mitochondria, internal stimuli induce the translocation of pro-apoptotic molecules
such as Bax to the ER. Bak translocation leads to the disruption of calcium
homeostasis and accumulation of unfolded proteins in the ER, which result in
activation of caspase-12, caspase-9 and finally cell death (Scorrano et al., 2003).  In
addition PD “in vitro” models induced by 6-hydroxydopamine, MPP+, and Rotenone
show a striking increase in transcripts associated with the unfolded protein response,
phosphorylation of the key endoplasmic reticulum stress kinases IRE1alpha and
PERK (PKR-like ER kinase) and induction of their downstream targets (Ryu et al.,
2002). The potential importance of Bax in PD is strengthened by the observation that
Bax null mice are resistant to nigrostriatal cell death induced by MPP+(Vila et al.,
2001).
3-7.  Models for Parkinson disease MPTP, 6-OHDA, and Rotenone
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to 1-methyl-4-phenylpyridine (MPTP)
is a by-product of the chemical synthesis of meperidine analogue with a potent
heroin-like effect that can induce parkinsonian syndrome in humans with specific loss
of the nigral dopaminergic neurons (Langston et al., 1983). Since the discovery of
MPTP, as a Parkinsonism causing substance in humans and primates, and other
mammalian species, this neurotoxin has been extensively used as a model for
Parkinson disease. From neuropathological data, MPTP administration appear to
cause damage to the nigrostriatal pathway recapitulating the progressive
dopaminergic loss in PD. Postmortem analysis of PD brains, reveal a selective
impairment of the mitochondrial electron transport chain, which is affected by MPTP
(Gluck et al., 1994). Following systemic administration, MPTP rapidly crosses the
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blood brain barrier and it is metabolized to 1-methyl-4-phenyl-1,2,3,6-
tetrahydropyridine to 1-methyl-4-phenyl-2,3-dihydropyridinium (MPDP+) by the
enzyme monoamine oxidase-B (MAO-B) in non-DA cells, and then by spontaneous
oxidation it is transformed to 1-methyl-4-phenylpyridinium (MPP+), which is taken up
by the dopamine transporter. Once inside the DA neurons, MPP+ is concentrated
through an active process in the mitochondria. There it impairs mitochondrial
respiration by inhibiting complex I of the electron transport chain. Inhibition of the
complex I blocks the flow of electrons along the mitochondrial electron transport
chain, which results in an increased production of ROS leading to DNA damage. Cell
damage is sensed by p53 (Mandir et al., 2002), which in turn up-regulates Bax
(Thornborrow et al., 2002), Bax is then translocated to the mitochondria, propagating
the apoptotic cascade. Administration of 6-hydroxydopamine (6-OHDA) was the first
PD animal model. Its toxicity is selective for monaminergic neurons, resulting from
its preferential uptake of by the dopamine transporter. As 6-OHDA cannot cross the
blood brain barrier it has to be administered by intracranial injection, it is then
oxidized by molecular oxygen and/or MAO B, and leads to the production of
intracellular H2O2, and reactive oxygen species. Indeed overexpression of glutathione
peroxidase, the enzyme, which metabolizes hydrogen peroxide to water, can prevent
or slow down neuronal injury in 6-hydroxydopamine-induced toxicity (Bensadoun et
al., 1998). In addition 6-OHDA can cause impairment of mitochondrial respiratory
chain via complex I inhibition (Beal, 2001). Recently studies report that 6-OHDA is
Fig I.6 Cascade triggered by the neurotoxin
affecting the DA neurons. The toxicity to
dopamine neurons is  exerted via
mitochondrial dysfunction and oxidative
damage. 6-OHDA is taken up by the dopamine
transporter and then generates free radicals.
MPTP is converted into MPP+ by monoamine
oxidase MAO B on oligodendrocytes, is then
taken up by the dopamine transporter,
accumulates into the mitochondria where
causes complex I inhibition and generation of
free radicals, or by the vescicular monoamine
transporter thereby reducing its toxicity.
Rotenone acts by directly inhibiting complex I.
MPTP and Rotenone cause LBs formation.
(Adapted from Beal , 2001)
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also formed endogenously in patients suffering from Parkinson's Disease (Glinka et
al., 1997).
Rotenone is a common pesticide used in vegetable gardens, and to select fish
population in lakes or reservoir. Chronic infusion of Rotenone in rats has shown to
recapitulate most of the pathological hallmarks of Parkinson´s disease. Once given
systematically it crosses rapidly the blood-brain barrier and binds and inhibits
complex I uniformly through out the brain, but induces activation of the
mitochondrial apoptotic cascade only in the mDA neurons. This reinforce the concept
that nigral DA neurons display a particular sensitivity to complex I inhibition
(Betarbet et al., 2000). Both oxidative damage and cytochrome c release subsequent
to complex I inhibition enhance a-synuclein aggregation in nigral neurons, and
formation of cytoplasmatic inclusion reminiscent of LBs in PD (Perier et al., 2003;
Trojanowski, 2003). In addition recent studies reported that rotenone is activating
resident microglia triggering an inflammation response, which may contribute to the
progressive neuronal demise in PD (Gao et al., 2002, 2003). This inflammatory
response is also observable in other animal model for PD and postmortem brain of PD
patients, which suggest that this phenomenon may take actively part in the
progression of the pathology (Orr et al., 2002; Hirsch et al., 2003).
3-8. Targeting apoptosis in Parkinson disease
A closer insight of the apoptotic cascade in PD and PD models has offered a concrete
possibility for the treatment of Parkinson disease. Approaches aiming to inhibit
apoptosis at the level of the effector caspase were yet unfruitful, whereas blockade of
the cascade upstream caspase activation resulted more successful. A broad-spectrum
caspase inhibitor Val-Ala-Asp-fluoromethylketone (zVAD-fmk) attenuates the loss of
DA neurons exposed to MPP+ in culture but does not restore neurites regression
(Bilsland et al., 2002).
Preventing only the death of the nigral cell body without preventing the degeneration
of their axonal processes has not resulted an helpful therapeutic strategy, but suggest
us that the molecular pathways that lead to the demise of the some are different from
those governing axonal degeneration.
Additionally attempts to prevent the progression of the pathology have been pursued
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by use of antinflammatory agents, since inflammation in Parkinson´s disease is
recognized to contribute to further dopaminergic degeneration. Inhibition of either
COX-1/COX-2 by acetylsalicylic acid or preferentially COX-2 by meloxicam
provided a clear neuroprotection against MPTP-toxicity on the striatal and nigral
levels (Teismann and Ferger, 2001) In addition thalidomide, a sedative,
immunosuppressive, and anti-inflammatory agent, which inhibits the TNF
transduction pathway, showed a dose-dependent protection against the MPTP-induced
decrease in DA (Boireau et al., 1997).
Prevention of apoptosis in PD models was also pursued through genetic targeting,
Transgenic mice overexpressing p35, a general caspase inhibitor for both initiator and
effector caspase, shows attenuated MPTP-induced cell death and striatal DA depletion
(Viswanath et al., 2001).
3-9. Clinical treatment of PD
Since the mid-1960s a symptomatic therapy that replaces the neurotransmitter with its
precursor L-DOPA has been the most common treatment for PD. This is usually
administered with a peripheral decarboxylase inhibitor to prevent formation of
dopamine in the peripheral tissue and a catechol-O-methyltransferase (COMT) to
increase the plasma half–life of levodopa. This therapy is very efficient in the early
phase of the treatment however in the later phases about 60% of the patients develop
severe complications such as motor fluctuation and diskynesia (Bezard et al., 2001).
Other drugs like dopamine agonists (Rascol et al., 2000) are also potential therapeutic
agents that don’t show a wear off effect as levodopa but are more likely to cause
hallucinations confusion, particularly, in elderly.
Intracerebral transplantation of embryonic ventral mesencephalic tissue is a potential
treatment for patients with Parkinson's disease for whom medical management is
unsatisfactory. Neural transplantation for Parkinsonism has been studied
experimentally in animal models of Parkinson's disease for more than two decades.
These animal studies have shown significant graft survival, synapse formation, graft
induced-dopamine release, and behavioral recovery in transplanted animals
(Ramachandran et al., 2002).
300 patients worldwide have undergone neural transplantation of embryonic ventral
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mesencephalic tissue. Among those, only in two bilaterally transplanted patients, graft
survival and host reinnervation was achieved and the patients showed clinical
improvement (Kordower et al., 1995), however in all cases functional recovery was
incomplete. Logistical and ethical issues have impeded up to now large scale clinical
trials and have increased the search for alternatives to human fetal cell grafts
including engrafts, stem cells, genetically engineered cells, immortalized cell lines,
and paraneural cells secreting specific neurotrophic and growth factors (Borlongan
and Sanberg, 2002).
Since surgical therapy is now becoming increasingly available, stereotaxic brain
stimulation of the subthalamic nucleus reduces significantly bradikynesia, rigidity and
tremor and is regarded by now as the most successful therapy against Parkinsonism
(Limousin et al., 1998).
4. Development of the midbrain DA neurons
4-1. Midbrain patterning and specification
The central nervous system arises from the neuroectoderm, which is generated briefly
after gastrulation. The neuroectoderm begins to thicken and subsequently rolls up
along it’s anterior-posterior axis (AP) to form the neural tube which partitions at its
rostral end into the basic subdivisions of the vertebrate brain, the fore-, mid- and
hindbrain (Lumsden and Krumlauf, 1996; Rubenstein and Beachy, 1998), clearly
distinguishable by day E9.5. This rostrocaudal patterning is followed by the dorso-
ventral (DV) polarization of the neural tube (Lee et al., 1999 and Simon et al.1995),
which is induced by two antipodal signals, sonic hedgehog, Shh, released by both the
floor plate (FP) and notochord, and bone morphogen proteins, BMPs, first released by
non-epidermal ectoderm and later by roof plate cells (Lee and Jessell, 1999). At this
time transcription factors expressed along the AP axes start to define the region were
the DA neurons are formed. At E7.5 the anteriorly located Otx-2 expressing tissue and
the posteriorly located Gbx-2 confront each other along the rostrocaudal axis, defining
the midbrain hindbrain boundary (MHB) or isthmus, which represent the border
between mesencephalic and metencephalic compartment, (Wassarman et al., 1997).
Thereafter two other transcription factors, Pax-2, followed by Pax-5, appear at the site
of confrontation (Wassef and Joyner, 1997). Parallel to Pax-2 the expression pattern
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of the two secreted molecules Fgf-8 and Wnt-1 become restricted to the adjacent
transverse band of the Otx-2/Gbx-2 border (Fig I.7) (Wilkinson et al., 1987; Crossley
and Martin, 1995). Homozygous mutant mice null for Otx-2, Wnt-1 and the double
mutant for Pax-2/5 all show the same phenotype with respect to the midbrain, a
complete deletion of it (McMahon and Bradley, 1990; Acampora et al., 1995; Ang et
al., 1996; Schwarz et al., 1997). At E9, 5, En-1 and En-2, similarly to Pax-5, span an
expression domain at the midbrain-hindbrain boundary (MHB) (Liu and Joyner,
2001a).
4-2. Induction of the midbrain dopaminergic neurons
In mammalian nervous system individual neurons develop at stereotypic positions
defined by their coordinates along the anterior-posterior (AP), dorsal–ventral (DV)
(Tanabe and Jessell, 1996). The three organizing centers, the midbrain hindbrain
boundary (MHB), the floor plate (FP), and the anterior neural ridge (ANR), are
positioned along the two main axes and specify the neuronal location and the
dopaminergic fate of the progenitor cell within the grid of Cartesian coordinates
(Rubenstein et al., 1994). This is also true for the mDA neurons (Hynes and
Rosenthal, 1999). The midbrain and forebrain DA neurons are specified by the
intersection of two signals arising respectively from the floor plate and MHB. Ectopic
induction of a second floor plate in dorsal location is accompanied by generation of a
cluster of DA neurons (Hynes et al., 1995b). The inductive potential FP tissue resides
in its secreted molecule Shh, in fact recombinant Shh, alone, is able to induce ectopic
expression of mDA neurons (Hynes et al., 1995a) and antibody directed against Shh
ablate its effect (Ye et al., 1998).
Fig I.7 Simplified scheme of Otx2, Pax2,
Pax5 and Wnt-1 expression pattern of at
E8 and E9 in mouse. Otx2, Pax2, Pax5 and
Wnt-1, which are represented by bars above
the embryo, appear in temporal order starting
from Otx2, and show an expression overlap
in the midbrainregion rostral to the isthmus F
= forebrain, M = midbrain, H = hindbrain
.
23
Along the dorso-ventral axis, the MHB (Gardner and Barald, 1991; Martinez et al.,
1991) and the ANR are the main source of Fgf-8 and provide inductive signals for the
mDA neurons and the forebrain DA respectively The isthmus, itself, can induce DA
neurons in ectopic ventro-caudal forebrain explants (Ye et al, 1998) and blocking the
activity of Fgf-8 in mid-forebrain explants prevents the development of both the
midbrain-forebrain DA neurons (Ye et al., 1998). In addition mice knocked out for
Fgf-8 lack any DA neurons (Ye et al., 1998).
Thus, the two inducing signal Shh along and Fgf-8 can control the dopaminergic fate
along the AP and DV axis respectively, but concurrent activation of both signals
seems to necessary and sufficient requirement for the induction of the DA neurons at
multiple site along the anterior neural tube (Fig I.8) (Ye et al., 1998).
The first postmitotic DA neurons are detectable at E9.5 as scattered faintly stained TH
positive cells along the ependymal layer at the medio-basal part of the mesencephalon
and upon formation, start to migrate first ventrally along tenascin bearing radial glial
processes, then laterally along neurofilament and L1 positive tangential fibers
(Kawano et al., 1995; Ohyama et al., 1998). By E12 the mDA neurons are distributed
throughout the entire length of the mesencephalon (Kawano et al., 1995). As soon as
the mDA are induced they start protruding an axon by responding short range guiding
molecules, such as the extracellular matrix protein (ECM) laminin, fibronectin and
tenascin (Lander, 1987), membrane bound molecules that can be cleaved and act a
soluble signal as L1 (Walsh and Doherty, 1997), glycosamminoglycans (Mace et al.,
2002) and astrocytes secreted factors (Johansson and Stromberg, 2002). Recent
studies have reported that the primary neurites extension of the mDA neurons in the
mesencephalon is dictated specifically by the permissive substrate provided by lateral
(L) radial glia and it is hemmed by the medial (M) radial glia and the repulsive
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Fig I.8 Cartoon depicting the positional
induction of mDA neurons. mDA neurons
are induced  at E12 at the crossover of
SHH released by the Fp and FGF8 by the
Istmus . SHH = sonic hedgehog, FGF8 =
fibroblast growth factor 8, fp = floor plate,
is = isthmus, F = forebrain, M = midbrain,
H = hindbrain
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molecule netrin at the midline (Cavalcante et al., 1996; Garcia-Abreu et al., 2000). A
few days later around E14, the nigral dopaminergic axons have reached the striatum
and the dopamine transporter DAT start to be expressed. The mechanism for the
axonal attraction is unknown, however from studies in vitro and vivo it has been
shown that the striatum can function as an attractive cue for the developing axons
(Manier et al., 1997) and that striatal glia induce axon elongation rostrally (Rousselet
et al., 1990). At E15 the nuclei of the SN laterally and the VTA more ventrally to the
neural tube are distinguished (Paxinos, 1995). The two nuclei have developed
projection towards different areas, the SN project to the caudate putamen and VTA to
the nucleus accumbens and olfactory tubercule forming respectively the nigrostriatal
and mesocorticolimbical pathway. The specificity for this pathfinding-choice between
the two populations is determined by the differential expression of the receptor
EphB1 and the ligand ephB2. Ligand and receptor are expressed in complementary
pattern in the midbrain dopaminergic neurons and their targets, which is consistent
with their repulsive interaction. The receptor EphB1 is expressed at high level in the
SN but at low levels in the VTA. In turn the ligand eph-B2 is expressed at high levels
in the nucleus accumbens and olfactory tubercule, but at low levels in dorsal striatum.
Thus SN dopaminergic neurons, that express high level of the receptor EphB1, project
to the caudate putamen (dorsal striatum), which, in turn, express low level of ephrin
B2. Conversely VTA neurons, which express low levels of the receptor, project to the
ventromedial striatum where high levels of ephrin B2 are transcribed (Yue et al.,
1999). At E15 the first functional synaptic connections are being established and
dopamine is first detected in the striatum (Perrone-Capano and Di Porzio, 2000). In
addition a mutual trophic interaction between the striatal target tissue and the nigral
dopaminergic sets on. Evidence for a retrograde trophic activity of the striatum on the
afferent dopaminergic neurons is provided by in vivo experiments where striatal
excitotoxic lesion in immature rat induces apoptotic cell death in the SN (Macaya et
al., 1994) and axon-sparing lesion of the striatum during development is associated
with an induction of apoptotic cell death in the substantia nigra (SN)(Kelly and
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4-3. The maturation phase
4-3-I. Extracellular factors
Once the midbrain dopaminergic neurons have become postmitotic other factors
responsible for the maturation and later specification come into play.
Nerve growth factors such as brain derived neurotrophic factor (BDNF) (Alonso-
Vanegas et al., 1999), neurotrphin-3,-4 and 5 (Hyman et al., 1994; Studer et al.,
1995), bFGF (Ferrari et al., 1989), members of the transforming growth factor, TGF-
a (Blum, 1998) and TGF-b (Farkas et al., 2003), GDNF protein families (Horger et
al., 1998; Strelau et al., 2000), and Thrombin (Debeir et al., 1998) support survival
and regulate axonal processing and branching. The SN of TGF-a knockout mice
contained 50% fewer dopaminergic neurons than the control littermates, whereas
VTA neuron number remained unchanged. This suggests that TGF-a takes part in the
differentiation of these dopaminergic nuclei (Blum, 1998). Other factors, such as
pituitary adenylate cyclase-activated polypeptide (Takei et al., 1998) calcitonin gene
related polypeptide (Burvenich et al., 1998) endothelin (Webber et al., 1998),
neurotensin (Sotty et al., 1998), estrogen and progesterone (Kritzer and Kohama,
1998) whose receptor are expressed in the mDA neurons may play a role in the late
specification of these neuronal subtype or serve as mitogenic factors for DA
progenitor maturation and survival support of this neuronal population.
4-3-II. Intracellular mediator
More recent studies have been focusing in understanding the role of the intracellular
signals. Until now five transcription factors have been identified: Nurr-1, Lmx-1b,
Ptx-3, En-1 and En-2, and they are known to be actively involved in the development
of the mDA neurons, however none of those alone can induce DA neurons in the
midbrain.
When the midbrain DA progenitor are still mitotically active at E7.5 they start
expressing Lmx-1b (Smidt et al., 2000) and further on development, at E9,5, aldeyde
dehydrogenase-2 (AHD-2) is detected (Wallen et al., 1999). After the first mDA
neurons have become postmitotic and begin to differentiate upon the induction of Shh
and Fgf-8, they express the transcription factor Nurr-1 (Zetterstrom et al., 1997) and
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just one day later at E11, the homeodomain transcription factor Ptx-3 (Smidt et al,
1997), and thereafter at E11.5 the homologous transcription factors En-1 and En-2. At
this stage the neurons start to express TH and L-aromatic amino acid decarboxylase
(AADC), as well as other protein that are necessary for the dopamine function, the
dopamine Transporter (DAT) and the vescicular monoammino transporter
(VMAT)(Foster et al., 1988; Fujita et al., 1993; Lee et al., 1999).
Nurr-1
Nurr1 (also known as RNR1, Not or HZF-1) is a member of the steroid/ thyroid
hormone nuclear receptor family, and acts as a ligand-activated transcription factor.
Binding to NBRE-like motifs (i.e. NL1, NL2 and NL3) proximal to the TATA box of
the TH promoter leads to Nurr-1 transactivation and TH gene transcription (Kim et
al., 2003). Nurr-1 expression can be induced by Fgf-8 alone(Ye et al., 1998). Nurr-1
is expressed in at least 95% of all TH positive midbrain neurons (Backman et al.,
1999). It is not resposible for the  induction of this neuronal phenotype(Hynes and
Rosenthal, 1999), but it plays a key role in the determination of the dopaminergic
phenotype, by regulating expression of TH, and AADC, DAT and VMAT. Knock out
mice for Nurr1 don´t express any of those genes , seem to develop normally during
embryogenesis, and die briefly after birth, since they are unable to feed (Zetterstrom
et al., 1997; Castillo et al., 1998; Sakurada et al., 1999). The use of Nurr1
independent markers for mDA neurons, such as AHD2, En1, Ptx-3 and a Nurr1
riboprobe 5’ to the deletion, revealed that the cells otherwise develop normally in the
mutant embryos until E15.5. At birth there are still some DA neurons left, principally
in the VTA, as shown by continued expression of the markers (Wallen et al., 1999).
Studies on the mutant phenotype remain contradictory, one group report that the
neurons in the Nurr1 mutants are abnormally distributed, no axons are traceable from
the striatum and a high amount of apoptotic nuclei is present in the ventral midbrain
(Wallen et al., 1999).The other group undergoing the same phenotypical analysis was
unable to observe any of the above mentioned alterations (Witta et al., 2000). An
explanation for these different observations could be that the investigated mutant mice
are the results of two separate experiments using different constructs. The first group
removed exons 2, 3 and part of 4 whereas the second group removed only exon 3. It
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is, therefore, possible that a partial Nurr-1 protein is still translated in the latter case
resulting in a weaker phenotype.
Lmx-1b
Lmx-1b is a member of the lim-homeodomain family of proteins. It is an essential
regulator for dorso-ventral patterning of the developing limbs (Johnson and Tabin,
1997), and participates in the regionalization of the midbrain-hindbrain (Adams et al.,
2000). Lmx-1b loss of function mutation lead to nail patella syndrome (Chen et al.,
1998; Knoers et al., 2000). It is expressed in the neural tube as early as E7.5,
including the region of the ventral midbrain which gives rise to the mDA neurons and
its expression in this neuronal population is maintained throughout life (Smidt et al.,
2000). In the E12.5 Lmx1b-/- mutant embryos few cells, corresponding to the VTA,
express TH and Nurr-1, but not Ptx-3, indicating that Ptx-3 is not necessary for TH
expression, further on in development by E16.5 the VTA neurons are lost. However
TH expression is maintained in other region of the brain in the DA and
neuroadrenergic system. The absence of Ptx-3 expression in the TH positive neurons
suggests that Lmx-1b is essential for the proper specification of the midbrain DA
neurons. In the Lmx-1b-/- mice lack of necessary molecular signals seem to impair
survival of the mDA neurons during development.
It appears that the molecular pathway of Lmx1b, together with the one Ptx-3, is
distinct form the one of Nurr-1.
Yet the published data is rather limited and the question remains open whether the
ablation of the mDA neurons in the mutant is due to a cell-autonomous requirement
of Lmx-1b in the neurons or an effect of the large midbrain deficit also observed in the
mutant animals. In chicken, the expression of Lmx1b is followed with a slight delay
by the expression of Wnt1 and gain of function experiments using a replication-
competent retroviral vector (Lmx1b/RCAS) suggest that Lmx1b is required for the
onset and maintenance of the Wnt-1 expression (Adams et al., 2000) If this interaction
also exists in mouse, then the Lmx-1b mutant phenotype with respect to the mDA
neurons is likely to be a consequence of the lack of Wnt1 expression in the midbrain
speaking against the notion of a cell autonomous requirement of Lmx-1b in the mDA
neurons.
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Ptx-3
Pitx3, also known as Ptx3, (paired-like homeodomain transcription factor 3 or pituary
homeobox 3) is a homeodomain containing transcription factor with binding activity
to DNA similar to the drosophila bicoid. It is uniquely expressed in the brain by the
mDA neurons from E11.5 onwards and is maintained throughout the entire life of the
animal (Smidt et al., 1997). Recent studies report that in the Pitx3-deficient aphakia
mice subsets of mDA neurons are progressively lost by apoptosis during fetal
(substantia nigra, SN) and postnatal (ventral tegmental area) development, resulting in
very low striatal DA and akynesia (Hwang et al., 2003; van den Munckhof et al.,
2003). This suggests that Pitx3 is required for motor activity and for survival of a
subset of midbrain dopaminergic neurons.
Engrailed-1 and 2
The mammalian Engrailed genes, En-1 and En-2, are homeodomain transcription
factors, which were originally cloned on the basis of their sequence similarity to
Drosophila engrailed or invected (Joyner et al., 1985; Joyner and Martin, 1987). As in
insects, they have two distinct ontogenetic roles. During early embryogenesis, they
take part in the regionalization of the embryo (Kornberg, 1981; Wurst et al., 1994;
Tabata et al., 1995) whereas during later embryogenesis they are involved in the
specification of neuronal phenotypes (Condron et al., 1994; Lundell and Hirsh, 1998;
Saueressig et al., 1999; Simon et al., 2001).
Both En-1 and En-2 genes start to be expressed at E8 in the anterior mouse
neuroectoderm as a marked band of cells, which will later give rise to the MHB. The
two transcription factor are patterning genes for the midbrain in different animal
models, such as chicken, mice and zebrafish (Wurst et al., 1994; Araki and
Nakamura, 1999; Scholpp and Brand, 2001). The mechanism proposed for the role for
En in the maintenance of the midbrain identity suggests a negative regulation exerted
by En on repressors of mesencephalon-related genes (Araki and Nakamura, 1999).
Between E11 and E12, the two genes emerge in the postmitotic mDA neurons and are
then continuously expressed throughout the entire life of the cells (Fig I.9)
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4-4. The dopaminergic phenotype
Fig I.9 En-1 and En-2 are expressed specifically in the mDA neurons. In situ hybridization
(A,C) and double immunostaining (C,D) respectively on P0 mouse brain saggital and coronal
sections. A,B adjacent section of a P0 wild-type mouse hybridized with  riproprobes for En-
1(A) and En-2(B), reveal the distribution of Engrailed at transcript level, En-1 is expressed at
high levels both in VT and SN, whereas En-2 is highly expressed only in a small subset of
cells and in the cerebellum. C,D Immunohistochemistry on P0 wild-type coronal sections
using a the aEnhb antibody, recognizing both  En-1 and En-2 proteins (C,red) and an antibody
against TH(D, green). En and TH are coexpressed in the mDA neurons of the SN and VTA.
Engrailed is nuclear and TH is located in cell somata and axonal processes.
mDA mDA
En-1 En-2A B
SN
VTA
SN
a-Enhb
TH
C
D
Fig I.10 Loss of the midbrain dopaminergic neurons
in the En double mutant. Nissl staining (A,D),
immunohistochemistry on saggital section of P0 mouse
brain using an antibody  against TH to identify the DA
neurons (B,C,D,E) of wild type (WT) and En double
mutant (En-1-/- En2-/-) mouse, TH immunostaining
reveals the natural distribution
of the midbrain DA
neurons. At the midline
(B) the VTA neurons are
labeled and in a    lateral
section (C) those of the SN
are labeled. In the double
mutan t  an imal  for
Engrailed neither the VTA
(E) neurons nor the SN(F)
are to be detected by TH
immunostaining , however
DA neurons of the dorso-
medial  hypothalamic
nucleus (DMH)remain to
be observed (E) clearly
indicating that their DA
phenotype is independent
of En-1  and EN-2 genes.
(Adapted from Simon et
al., 2001)
A B C
D E F
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(Davis and Joyner, 1988; Gardner and Barald, 1991; Simon et al., 2001) Mice
homozygous for an En1 null mutation die at birth and lack the inferior colliculus and
parts of the cerebellum (Wurst et al., 1994). The mutant mice for En2 are viable and
fertile, and show only a minor defect in cerebellar foliation (Joyner et al., 1991a;
Millen et al., 1994).
In chick, retrovirus-mediated misexpression of En genes (Friedman and O'Leary,
1996; Itasaki and Nakamura, 1996; Logan et al., 1996; Shamim et al., 1999), within
the developing mesencephalon  results in a defect of the cytoarchitectonic
organization of the optic tectum, abnormal arborization, and mistargeting of nasal
retinal ganglion cell (RGC) axons and complete degeneration of the temporal RGC
axons.
It has been previously described by Simon et al,2001  that both genes are involved in
the development of the mDA neurons, and that their function is redundant in respect
to the generation and maintenance of this cell population. The requirement for the
Engrailed genes is apparent in the absence of both En-1 and En-2. In En double
mutant the mDA are generated, express TH fail to differentiate and disappear (Fig
I.10)(Simon et al., 2001). Furthermore, the mutant analysis also provided evidence
that the expression of a- Synuclein is missing when both En genes are knocked out,
suggesting a direct regulation of the transcription factors on the expression of a-
Synuclein (Simon et al., 2001).This is particularly interesting since two human point
mutations in the a-Synuclein gene have been recently linked to familial form of PD
(Polymeropoulos et al., 1997; Kruger et al., 1998)
4-4. The dopaminergic phenotype
Once the midbrain dopaminergic neurons have become postmitotic they continue
differentiating and start expressing functional markers asynchronously. The first
phenotypical marker to be expressed is tyrosine hydroxylase TH, followed by the
synaptic vesicle monoamine transporter VMAT2, the glial derived factor receptor
alpha, GFR-a1, receptor kinase, c-ret. TH is the rate-limiting step of DA synthesis,
which transforms L-tyrosine into L-DOPA. VMAT2 belongs to a larger family of
vesicular monoamine transporter and is responsible for the storage of monoamines
into a dense core of vesicles in most monoaminergic neurons (Amara and Arriza,
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1993). GFR-a1 colocalize with the, c-ret, which is activated upon binding with
GDNF and promotes survival and sprouting of the mDA neurons (Sauer et al., 1995;
Tomac et al., 1995; Gash et al., 1996; Akerud et al., 1999).
DAT modulates DA uptake, and is the site of action of various psychostimulant drugs
and neurotoxin. Homozygous DAT null mice show spontaneous locomotion due to
protracted persistence of DA in the extracellular space and are insensitive to the
action of amphetamine, cocaine and the specific DA toxin 1-methyl-4-phenyl-1,2,3,6-
tetrahydropyridine (MPTP)(Drago et al., 1998; Bezard et al., 1999) From data in vitro
it appears that DAT expression and DA uptake are modulated by the target striatal
cells which further support the hypothesis that the striatal target would contribute to
the maturation and support of the dopaminergic neurons (di Porzio and Estenoz, 1984;
Perrone-Capano and di Porzio, 1996).
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MATERIALS and METHODS
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1. Generation and maintenance of mice
The generation of the En-2 deficient mice by targeted gene deletion has been
previously described (Joyner et al., 1991b). The En-1 tau-lacZ mice were generated
by a knock in strategy were the first 71 codons, including the first codon, are replaced
by a Tau-lacZ sequence TLZ (Callahan and Thomas, 1994), and resulted in the En1
null allele. Construct and procedure are described by Sauressig et al., 1999. Parental
lines both En-1TLZ/+ En-2-/- produce the double null mutant mice for En-1 and En-2
.The initial tail genotyping for En-2 wildtype and mutant alleles was performed by
PCR using the three primers to detect in one reaction wild-type and mutant alleles
(neo). `Common´ primer 5´-TTGAGAAGAGAGGCCCTGTA-3´, `wild-type´ primer
5´-CTGGAACAAAAGGCCAGTGT- 3 ´ ,  ` n e o ´ p r i m e r  5 ´ -
TCTCATGCTGGAGTTCTTCG-3´. PCR parameters: 5 min at 94°C, 36 cycles ( 45
sec at 94°C, 1min at 54°C, 1 min at 72°C), 5 min at 72°C, PCR conditions: 2.5 mM
MgCl2. The tails genotyping for the En-1TLZ allele was done by PCR using two
primers `TLZ´ 5´-GTGTCCGGCAGCTTGGTCTT-3´ ,   `EN1s´  5´-
TTCGCTGAGGCTTCGCTTTG-3´ PCR parameters: 4 min- 94°C, 30 cycles (45 sec
at 94°C, 1min at 54°C, 1 min at 72°C), 4 min  at 72°C, PCR conditions: 2.5 mM
MgCl2.
2.  Genomic DNA extraction
Tail biopsies from 2-3 weeks old mice were obtained and stored at –20°C. The tissue
for genomic DNA extraction was first digested overnight at 55°C in proteinase K
buffer [50mM Tris pH 8, 100mM EDTA, 100mM NaCl, 1%SDS supplemented with
5mg/ml proteinase K (Applichem, Germany)]. DNA extraction was performed in high
salt solution. 200µl 5M Nacl were added, the mixture was shaken vigorously and
centrifuged for 10min at RT. The supernatant was then collected and one volume of
cold 95% Ethanol was added, the precipitated DNA was spooled out and placed in a
new Eppendorf tube. Precipitated DNA was rinsed with 70%Ethanol and then
resuspended into 100-500µl TE (10 mM Tris pH=8, 1mM EDTA). The DNA was
finally heated at 65°C from 2 hours to overnight and used for genotyping.
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3. Derivation of En-1-/- En2-/- stem cells
3-1. Preparation of feeder layer cells from mouse embryonic fibrobloblasts
E12-E14 mouse embryos were dissected under the hood in a dish containing fresh L-
15 (Cambrex, Belgium), Head, limbs and internal organs were removed. Once having
removed the plunger, the carcasses were sucked with a 5ml syringe and homogenized
through an 18-gauge needle L-15, until clumps were broken up. The slurry was then
transferred into two 50 ml falcon tubes containing 25 ml of Trypsin/EDTA (Cambrex,
Belgium). The tubes were incubated for 5-10 min at 37°C, and mixed occasionally by
inversion, until no clumps were visible. Trypsin was, then, inactivated by adding 25
ml of DMEM plus 10% of fetal bovine serum to each tube. The solution was pipetted
up and down several times with a 10 ml pipette. 100-200µl 5mg/ml sterile stock
DNAse I (Roche, Germany) was added to each 50 ml tube, incubated for 5min at
37°C and mixed by inversion, until the DNA precipitate was no longer visible. Cells
were then spinned down by centrifugation and resuspended in 5-10 ml of feeder
medium [DMEM, 10%fetal bovine serum (FBS), 50µg/ml penicillin and
streptomycin, 2mM glutamine]. The cells were plated into 10 cm tissue culture dish
per embryo. The medium was changed after 24 hours at 37°C and 5%CO2. Cell were
let grow to confluency and then frozen into DMEM supplemented with 20% FBS and
10% dimethylsulfoxide (tissue grade culture, Sigma-Aldrich, Germany) in aliquots of
1ml at a concentration of 4x106 cells per aliquot.
3-2. Mytomicin C treatment of fibroblast feeder cells
In order to prepare mitotically inactive fibroblast feeder layers, we used mitomycin C
(tissue grade culture Sigma, Germany). Confluent dishes of mouse embryo fibroblasts
on 0,1% gelatin were treated with DMEM plus 10% new born calf serum and 10
µg/ml of mytomicin C for 2 hours at 37°C and 5% CO2. The dishes were then washed
three times with PBS, and fresh ES medium [DMEM (high glucose, without
pyruvate), 15% fetal FBS ES cell tested (PAN, Germany), 2mM glutamine, 0,1mM
non-essential amino-acids (Invitrogen, Germany), b-mercaptoethanol (Invitrogen,
Germany), 50µg/ml penicillin and streptomycin, 2mM glutamine and leukemia-
inhibitory factor (LIF) 200U/ml (Chemicon, Germany)] was added at least 2hr at
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37°C before placing the stem cells. The rest of the mytomicin C treated mouse
embryo fibroblasts, were frozen down for future experiment in DMEM supplemented
with 20% FBS and 10% dimethylsulfoxide (Tissue grade culture Sigma-Aldrich,
Germany) in aliquots of 1ml at a concentration of 6x106 cells per aliquot.
3-3. De novo isolation of embryonic stem cells from E3.5 blastocysts
The uterine horns were removed from pregnant En-1-/+ En-2-/- mothers, and
surrounding fat was removed. The content of the horns was flushed using a 1ml
disposable syringe with M2 medium (Invitrogen, Germany) into a sterile concave
glass plate under a stereo dissecting microscope. The individual recovered blastocysts
were then aspirated with a drawn-out Pasteur pipette held in a mouth-controlled tube,
and placed into a 6 well plate precoated with feeder cells and ES medium. The
embryos hatching from the zona pellucida, attached within 24-36hr by growth of the
trophoblast cells. The spreading of the trophoblast component onto the substrate
resulted into the ICM component, visible in the tissue culture. The blastocysts were
left undisturbed for a period of 4-6 days of continuous culture. During this time ICM
cell clumps proliferated and gave rise to a small clump of cells. The ICM was then
disaggregated under a stereo dissecting microscope using a 200µl pipette, and the
disaggregated ICM was transferred into 3cm sterile dish with a drop of 200µl of
Accutase (PAA laboratories, Austria), pipetted gently and placed for 3 min at 37°C. A
drop of culture medium (200µl) was then added to neutralize the digestive enzyme
and with an extremely fine capillary, pulled from a Pasteur pipette. The ICM clumps
were repetitively sucked up and down to separate them into single cells. The content
of the drop was then transferred into the centre of the well in a 6 well plate precoated
with fresh feeder cells and containing ES medium. ICM-derived cellular aggregates
attached to the feeder layers and give rise to small colonies of cells within 4 days of
culture. Colonies were inspected and then classified into several broad types on the
bases of their morphology. Stem cell colonies colonies are typically small, have a
large nucleus and minimal cytoplasm, and are densely packed together into small
nests with individual cells at the edge of the colony.
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4. Immunohistochemistry
4-1. Processing of the embryonic specimen
 Mouse and Chicken embryo heads were fixed at 4°C overnight in 4% PFA in
100mM phosphate buffer (PB), pH 7,4. The heads were cryoprotected with 30%
sucrose in 100mM PB, and cut at the cryostat (Microm).
4-2. Processing of the whole mounts
The neural tube was dissected from E12.5 embryos and fixed in 4% PFA at 4°C
overnight. The day after the whole mounts were rinsed in blocking solution [1%Triton
PBS (PBT), 10%NCS] twice for 10 min, the specimen were then incubated for 1 hour
in blocking solution supplemented with 0,1% H2O2. Thereafter they were rinsed three
times for 10 min in PBT and incubated overnight at 4°C with the primary antibody,
rabbit anti TH, (AB152, Chemicon, Germany), diluted 1:1000 in blocking solution.
The next day the neural tube was washed three time for 1hour with PBT and
incubated overnight at 4°C with the secondary antibody, biotinilated goat anti rabbit
(Dianova, Hamburg), diluted 1:500 in blocking solution. The next day whole mounts
were washed three times with PBT for 1 hour and incubated overnight at 4°C with
streptavidin peroxidase (Dianova, Hamburg) diluted 1:1000 in PBT. On the next day
the neural tube was rinsed twice for 10 minutes in 100mM phosphate buffer pH 7.4,
and preincubated for 10 min with in 0,005% DAB in 100mM phosphate buffer pH
7.4. The color reaction was developed by adding a 100 mM pH 7.4 phosphate buffer
solution containing 0,005% DAB and 0,01% H2O2 .The reaction was then blocked by
washes in 100mM phosphate buffer pH 7.4. Following staining the neural tube was
cut at the midline and flattened in glycerol/PBS (9:1).
4-3. Immunohistochemistry
All immunostaining on cryostat sections, tissue and cell cultures were performed
using Rabbit anti TH (AB152, Chemicon, Germany) at the dilution 1:1000, Sheep anti
TH (AB1524, Chemicon, Germany) at the dilution 1:250, Rabbit anti-activated
Caspase-3 (9661 Cell Signaling, USA) at at the dilution 1:500 for cell culture and
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1:50 for tissue, Rabbit anti Pbx 1/2/3 (sc888 Santa Cruz, USA) at the dilution 1:2000,
Rabbit anti Nurr-1 (AB 5778, Chemicon, Germany) at the dilution 1:500, mouse
monoclonal anti-Engrailed 4g11( Developmental Studies Hybridoma Bank) as pure
supernatant, and mouse monoclonal anti-BrdU( 1170376 Roche Diagnostic,
Germany), mouse monoclonal anti L1(557, Gift of Schachner M.) as pure
supernatant, mouse monoclonal anti a;b-Tubulin (1111876, Boehringer Mannheim
GmbH, Germany). Coverslips and cryostat sections were postfixed in ice-cold
acetone for 5-10 min, washed with PBS three times for 2 min, and incubated for
30min in blocking solution (10%HS in PBS). Collagen tissue cultures were just
blocked in 10% HS 0,01%Triton PBS (blocking solution) for 1 hour at room
temperature. Collagen tissue culture coverslips and cryostat sections were incubated
overnight at 4°C with the primary antibody, diluted in blocking solution. On the next
day coverslips and slides were first washed for 5 min three times with PBS, for
collagen cultures washes were always performed with 0,01% Triton PBS. All samples
were then incubated for 1-2 hours with the secondary antibody diluted in blocking
solution. Biotinilated or directly coupled species-specific antibodies (Jackson Immuno
research, USA) with Cy2, Cy3, Cy5 or Horseradish peroxidase, Following incubation
with biotinilated secondary antibody, cell cultures, cryostat sections and collagen
cultures were washed and further incubated for 1 hour at room temperature with Cy2,
Cy3, Cy5 or Horseradish peroxidase strepatdavin (Jackson Immuno research, USA).
After immunostaining, cultured cells on coverslips and tissue sections were
counterstained with DAPI (236276 Roche Diagnostic, Germany)
 5. In situ Hybridization
5-1. Synthesis of mouse En-1 riboprobe
The mouse DIG En-1 riboprobe was synthesized from En-1 pBsk, linearized by
enzymatic digestion with Hind III. The digested DNA was incubated for 1-2hr at
37°C with T7 polymerase (Invitrogen, Germany), Trans 5x buffer (Promega,
Germany), 10x DIG labeling mix (Roche, Germany), 0,01 M DTT (Promega,
Germany), 1U/µl of RNAse inhibitor (Promega, Germany). After transcription had
taken place 10U/µl DNAse RNAse free were added for 15min at 37°C to get rid of
DNA residues. The DIG-probe was, then, precipitated adding 100µl TE, 1M LiCl,
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and 300µl 100% ethanol, for 30 min in dry ice and then centrifuged at maximum
speed for 10 min. The pellet was washed with 80% ethanol, and resuspended in
TE/formamide (50µl: 50µl), let for few minutes at 60°C or longer at room
temperature. The DIG-probe was checked on a 1% Agarose gel, and the concentration
at the spectrophotometer (RNA 230 and 260 nm), and eventually stored at –20°C.
5-2. In situ hybridization with mouse En-1 riboprobe
Chicken neural tubes were dissected in PB pH 7,4 carefully removing surrounding
mesoderm. Fixed in 4% PFA overnight and next day washed with methanol/
0,1%Tween-20 PBS (1:1), and twice with absolute methanol. At this point the
embryos can be put at –20°C for long-term storage.
The neural tubes were rehydrated, and postfixed in 4%PFA, 0,1% glutaraldehyde.
Thereafter they were submerged in the hybridization mix buffer containing 50%
formamide, 0,5% CHAPS, 0,2% Tween-20, 3x SSC, 5mM EDTA, 50µg/ml Yeast
RNA, 100µg/ml Heparin for 1hr at 70°C, after this preincubation the neural tubes
were transferred in a new hybridization mix containing 1µg/ml of the DIG labeled
mouse En-1 probe incubated overnight at 70°. On the following day the whole mounts
were washed twice with prewarmed hybridization buffer, once in 50 % hybridization
buffer and 50% Aqueous solution containing 1.3 M NaCl, 20mM KCl, 0,25 M Tris-
HCl pH 7.5, 0,1% Tween (TBST), and twice only with TBST at room temperature.
Neural tubes were then blocked in TBTS supplemented with 10% new born calf
serum (10%NCS-TBST) for 1 to 3 hours, and, then, incubated overnight with anti-
DIG antibody (Roche Diagnostic, Germany) diluted 1:5000 in 10%NCS-TBST. The
following day they were washed twice with TBST, and three times with an aqueous
solution containing 20mM NaCl, 50mM Tris-HCl pH 7.5, 25 mM MgCl2, 1%Tween
(NTMT). The color reaction was developed by adding NBT/BCIP (Roche Diagnostic,
Germany) in NTMT, and stopped at the desired staining intensity with 1M TE pH 8.
The whole mounts were dried and stored in 2-4% PFA in 0,1 M PB.
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6. BrdU labeling
BrdU (Sigma, Germany, 50mg/kg body weight) was injected intraperitoneally at
pulses of 6 hours per day from E10,5 to E12,5. To demask the BrdU, the PFA fixed
cultures were treated with DNAse (Roche Diagnostic), 0,05 mg/ml in PBS
supplemented with 5mM MgCl2 and 1mM CaCl2, for 5-10 min. BrdU incorporation
was detected using mouse monoclonal anti-BrdU (170376 Roche Diagnostic,
Germany) and following the standard immunohistochemistry protocol (4-3).
7. Coverslip coating
12mm glass coverslips (Neolab, Germany) were sterilized by flambation after
submerging them in 99% ethanol. Each coverslip was placed into a 24 well plate
(Corning, Germany). PORN/Laminin coating was performed by submerging the
coverslips in 10mg/ml polyornithine (Sigma, Germany), dissolved into sterile water.
The coverslips were then checked for uniform submersion and then left for 1 hour at
room temperature under the hood. They were then washed three times with sterile
water, in the meanwhile aliquots of 1mg/ml laminin were slowly thawed on ice,
diluted 1:1000 into DMEM or DMEM-F12 (Cambrex, Belgium), and added the
coverslips in the wells.
For the coating with membrane vesicles from wildtype ventral midbrain: 12 ventral
midbrain were dissected from E12.5 embryos in L-15 (Cambrex, Belgium). The tissue
was then transferred into 1.5 ml eppendorfs and most of the medium removed. 500ml
homogenization buffer supplemented with protein inhibitors, (HB inh) Aprotinin
10ml/ml and Pepstatin 1ml/ml (both from Sigma, Germany) was then added, and
homogenized with a1 ml syringe( 0,4 mm x 25 mm length) to a clear solution. The
solution was layered on a sucrose step gradient of 350ml 50% and 150ml 5% sucrose
dissolved in HB inh inside a 3ml polycarbonate tubes (Beckman- Coulter, Germany).
The tubes were centrifuged at 50000 g for 10 min in an ultracentrifuge Beckmann TL,
rotor TLS 55. After centrifugation the membrane fraction at the border line, between
50% and 5% sucrose, was collected with a micropipette, resuspended in 1ml PBS, and
spinned at high speed at 4°C. The supernatant was then discarded and the pellet
resuspended in 1ml PBS. Protein content was determined by diluting membrane
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suspension in 2%SDS 1:10, extinction factor was determined at 220 nm against 2%
SDS using a Beckman Coulter spectrophotometer. Membrane solution was then
diluted to 0,1mg/ml. 50 µl/ml red fluorescent covaspheres (Duke Scientific,
S.Antonio, California, USA), were added to one of the diluted membrane suspension
in order to verify by fluorescence labeling of the ventral midbrain membrane vesicles.
Membrane fraction were stored at –80°C. 150µl membrane suspension was then
layered onto PORN precoated coverslips, left 1-2hr at 37°C and then washed with
medium previous to cell plating.
8. Threedimensional collagen gels from rat tails
Frozen rat tails were put into 70% ethanol to slowly thaw. Tendons were then
removed and put in a large 6mm sterile dish, washed twice with 70% Ethanol. Tails
were, then, put in a flask, and weighted, washed twice with water, dissolved in 0,1%
Acetic acid and steered for 3 days at low speed to complete dissolution.
The solution was poured in 50 ml tubes, which were then centrifuged at 15000rpm for
2hr at 4°C. The supernatant was collected and poured in dialysis tubes, placed in 1l
flask, containing 1:10 BME10x (Gibco, Germany) in pH=4 water, and left to dialyze
for at least 3 days at 4°C with a stir bar. The collagen was then stored up to one year
into 5-10 ml aliquots.
The collagen gels were obtained by placing 9 parts of dialyzed collagen into a 1.5ml
eppendorf tube on ice together with 1 part of BME10x and 0,09 parts of pH=7.5
sodium bicarbonate (Sigma, Germany). The mixture was pipetted up and down
always on ice. Pellet of dissociated ventral midbrain was diluted to 1000 cells/µl into
the collagen gel. 150µl cell- collagen drops containing the cells were pipette into 4
well plates (Corning, Germany). Cell medium was added after 15-30 min, to allow
thickening.
9. Primary cell culture
All primary cell cultures were performed using E12.5 En-1 -/-, En-2-/- double mutant
mouse embryos. Mutant embryos were distinguished from their control littermates by
the characteristic midbrain hindbrain morphology (Simon et al., 2001). The
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embryonic ventral midbrain was carefully dissected into fresh L-15 (Cambrex,
Belgium) and meningis were removed. The ventral midbrain from the En double
mutant and control littermate were placed into separate tubes and dissociated using
Accutase (PAA laboratories, Austria). Cells were plated at a concentration of 150000
cells per well on precoated glass coverslips with Poly-ornithine/Laminin (both from
Sigma, Germany), membrane vesicles or 3-D collagen matrix. The medium was
DMEMF12 (Cambrex, Belgium) supplemented with 10% Horse Serum (HS) (Gibco,
Germany), 5% fetal calf serum (Gibco, Germany), 33mM glucose (Sigma, Germany),
50U/ml penicillin and 50mg/ml streptomycin (Cambrex, Belgium). Cells were
cultured from one hour to five days. In the cell mixing experiment, cell numbers of
mutant were each 75000 to a final concentration of 150000 as for the homotypic
cultures. For the RNA interference experiment, we always used serum-free medium-
DMEM-F12 supplemented with 1xN2 (Gibco), 33mM glucose, 50U/ml penicillin and
50mg/ml streptomycin.
10.  Neurointoxication
Ventral mesencephalic culture were first cultured for three days on PORN/Laminin
glass coverslips in DMEM-F12 (Cambrex, Belgium) supplemented with 10% horse
serum (HS)(Gibco, Germany), 5% fetal calf serum (Gibco, Germany), 33mM glucose
(Sigma, Germany), 50U/ml penicillin and 50mg/ml streptomycin (Cambrex,
Belgium), the third day of culture the medium was changed to serum-free medium-
DMEMF12 supplemented with 1xN2 (Gibco). At the fifth day of culture, cells were
exposed to 10µM MPP+ (Sigma, Germany), 100µM 6-OHDA, and 100µM Rotenone.
Cells were fixed 48 hours after intoxication and counterstained for En, Pbx, Nurr-1,
Lmx-1b, Ptx-3, and TH.
11. RNA interference in vitro
11-1. siRNA design
 21 nucleotide siRNA (small interfering RNA) were designed for En-1, lamin A/C,
Pbx-1, in order to contain uridine residues and 2-nucleotide 3´overhang (Elbashir et
al., 2002). The specific sequence within the coding region were produced and used for
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siRNA interference: si En1 5´-CAUCCUAAGGCCCGAUUUCTT-3´ and antisense
5 ´ - G A A A U C G G G C C U U A G G A U G T T - 3 ´ ,  s i  s c r a m b l e d  5 ' -
CAGTCGCGTTTGCGACTGG -3' sense and 5´- CCAGTCGCAAACGCGACTG-3´
antisense. The oligos, except for the scrambled oligos, were pursued by mwg-biotech,
International as 2´-acetylated single strand (option A2). Deprotection was performed
at arrival using 400µl deprotection buffer provided. The oligos were first incubated at
60°C for 45 min and then 30 min at room temperature. Annealing was performed
adding 40µl 10mM ammonium acetate (enclosed) and 1.5 ml ethanol to the 400µl
siRNA duplex solution, then vortexed. The RNA duplex was then placed at –20°C for
more than 16 hours or at –70°C for 2 hours. The duplex was centrifuged at maximum
speed for 30 min at 4°C, the supernatant pipetted away and the pellet rinsed with 95%
cold ethanol. The pellet is dried in a speed vacuum and resuspendend at the
appropriate concentration in 1x annealing buffer provided. The solution can be stored
frozen in aliquots at –20°C.
11-2. siRNA transfection
At the third day of culture of En2-/- ventral midbrain, siRNA oligos transfection was
performed using Transmessenger transfection reagent (Qiagen, Germany). siRNAs
(0,3 µg per well) were condensed with Enhancer R, and complexed with 1,5 µl of
Transmessenger reagent, according to the manufacturer instruction. The transfection
complex was diluted into 400 µl of N2Medium, and added to the cells. 2hours post
transfection the medium was replaced with fresh N2Medium. Cells were stained
following a time course after 1, 2, 3, 4, 5 days.
12. Caspase inhibition
En1-/- En2-/- and control littermate ventral midbrain were separately dissociated and
plated on to PORN/laminin precoated coverslips, cultured for 6 hours into DMEM-
F12 supplemented with 10x N2 (Gibco, Germany), 33mM glucose (Sigma,
Germany), 50U/ml penicillin and 50mg/ml streptomycin (Cambrex, Belgium), in
order to allow primary processing and conditioning of the cells. Medium was then
changed to fresh serum free medium-DMEM-F12 supplemented with 1xN2 (Gibco),
containing 300 µM zVAD-fmk (Calbiochem, USA) dissolved in DMSO (Sigma,
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Germany), or an equivalent volume of DMSO for control cultures. Cells were fixed
72 hours after plating, and stained for TH and DAPI and cells counted.
13. Real time PCR on E12.5 and E14.5 ventral midbrain tissue
13-1. RNA isolation
The ventral midbrain from En-1/2-/- E12.5 embryo and control littermate were first
dissected in fresh L15 medium (Cambrex, Belgium) taking care of removing
mesodermal tissue and meningis, and placed in RNA later solution (Qiagen,
Germany), at 4°C overnight, and the next day at –20°C for longer storage. At the time
of RNA extraction all the tissue pieces from the double mutant and control littermate
were collected, RNA later was sucked out, and lysis buffer provided with the RNA
extraction Kit (Qiagen, Germany) was applied. Each sample was passed through a
Qiashredder (Qiagen, Germany) and applied on an RNAeasy column (Qiagen,
Germany). The RNA was then treated with with RNAse free DNAse (Invitrogen,
Belgium) in order to get rid of DNA traces and repurified on RNeasy column. The
average yield of RNA was 1.5µg per ventral midbrain. Aliquots of 3 µg were snap
frozen in liquid nitrogen to avoid repeated thawing and freezing.
13-2. Reverse transcription
cDNA was prepared from 3 µg RNA obtained from En1/2-/-, control littermate
ventral midbrain, En1EGFP-+dox N2A clone, and En1EGFP-dox N2A clone. First
strand cDNA synthesis was performed with random hexamer primer by using
Superscript Preamplification System for First Strand cDNA Synthesis (Invitrogen,
Belgium) using a thermocycler. Reverse transcription was initiated using 1-5µg of
RNA, 50-250 ng of random hexamers, 1mM dNTP, incubated at 65°C for 5 min and
then at 4°C for at least 1 min. Thereafter the reaction containing 1x reverse
transcription buffer, 2.5mM MgCl2, 0,01DTT, and 50 U RNaseOUT recombinant
ribonuclease inhibitor was added to the solution and incubated at 25°C for 2 min, then
the reaction mix was incubated with 50 U of SuperScriptTMII reverse transcriptase at
25°C for 10 min. The tube was then transferred to 42°C and incubated for 50 min.
The reaction was terminated at 70°C for 15 min. Chilled at 4°C. The reaction solution
was centrifuged briefly and 50U of RNaseH were added to the tube and incubated for
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20 min at 37°C. Reverse transcription efficiency was verified by PCR using primers
for b -Actin sense 5´- CAACTGGGACGACATGGAGA-3´and antisense 5´-
TTTCATGGATGCCACAGGAT-3´. PCR parameters: 5 min at 94°C, 36 cycles (45
sec at 94°C, 1min at 57°C, 1 min at 72°C), 5 min at 72°C, PCR conditions: 2.5 mM
MgCl2.
13-3. Real time PCR
Quantification of the gene target, Trp53 and p75NTR in the sample En1-/-, En-2-/-
ventral midbrain, and En1EGFP+dox N2A was performed using the Standard curve
method (User Bulletin #2, Applied Biosystem). En-2-/- ventral midbrain and
En1EGFP-dox N2A clone were used as calibrator to build up a standard curve, of
known step dilution, from which, each quantity of the sample and calibrator are
derived. Endogenous control for mouse phosphoglycerokinase 1(PGK1), and mouse
transcription factor IID/TATA-box binding protein (Tbp) were used to normalize
quantization of a target mRNA for difference in amount of total RNA added to each
reaction. We used ready-to-use 5´fluorogenic nuclease assay for the target genes and
endogenous control assay for mouse phosphoglycerokinase 1(PGK1), and mouse
transcription factor IID/TATA-box binding protein (Tbp) (Assays-on-Demand from
Applied Biosystem, Germany, www.appliedbiosystem.com). Gene expression
quantification was performed using a two-step reverse transcription-polymerase chain
reaction (RT-PCR, default PCR parameters were 2min 50°C, 10 min 95°C 45 cycles
(15 sec-95°C, 1min-60°C), in which PCR step is coupled with the respective
5´fluorogenic nuclease assay, 5ng/µl of cDNA from En1-/-, En-2-/- ventral midbrain,
En1EGFP+dox N2A, and calibrator cDNA En-2-/- ventral midbrain, and En1EGFP-
dox N2A, were added to a reaction mix specific for each Assay [2x TaqMan
Universal PCR Master Mix, No AmpErase UNG, 20X Assays-on-Demand™ Gene
Expression Assay Mix (all products by Applied Biosystem)] and RNase-free water to
a final volume of 30-50 µl per well for a 96 well format. 30-50µl of each reaction
mixture were transferred to well of an optical reaction plate (Applied Biosystem,
Germany). Usually duplicates or triplicates of a sample were made. Standard dilution
curves with dilution values 1, 0.5, 0.25, 0.125 were set up for both target genes and
endogenous control using the calibrator cDNA. The plate was then covered with an
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optical adhesive cover, and centrifuged to spin down the content and eliminate any air
bubble. The reaction plate was then placed in an ABI prism 7000 sequence detector
system (Applied Biosystem, Germany) and the run started. The amplification trend
was followed during the run by viewing the amplification plot for the entire plate.
Once the run was terminated baseline and threshold were set. Data elaboration was
performed as following: the relative quantities of the target gene and the calibrator,
calculated both from the standard curve, were always normalized to the respective
standard curve derived target quantity of the endogenous control essay. The quantity
of the target gene of the sample was then divided by the target quantity of the
calibrator, so that all quantities were expressed as n-fold difference relative to the
calibrator.
14. Promoter analysis
The mouse p75 promotor sequence was first retrieved from the GeneBank ID by
using
http://www.ncbi.nlm.nih.gov, copied then to "Human gene sequence retrieval tool "
http://siriusb.umdnj.edu in the box "Value" and submitted for the region ranging from
–5000bp to +1000; the obtained sequence containing also the promoter region was
then analyzed for consensus sequence recognized by transcription factors using
the"MatInspectorV2.2" http://transfac.gbf.de/cgi-bin/matSearch/matsearch.pl. The
same promoter analysis was performed for the human p75 promoter. Strongly
conserved sequence between human and mouse >95% were found between –140 and
-340bp. In this conserved sequence highly matching consensus sequence for the
Drosophila engrailed at –140-180bp and the mammalian En-1 at –250-340bp
respectively were localized.
15. Retroviral construction and infection
The mouse En-1 coding region plus the first 19bp of the 3´untranslated region (Joyner
and Martin, 1987; Logan et al., 1992) was subcloned into the Cla12Nco adapter
plasmid using appropriate restriction sites within the polylinker. A ClaI fragment was
then purified following partial digestion of this vector with ClaI and cloned into the
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retroviral vector RCAS (BPA) and RCAN (BPA) generating RCAS En-1, and RCAN
En-1, respectively. RCAN (BPA) is a variant of RCAS (BPA) from which the splice
acceptor upstream the ClaI site has been removed, preventing translation of the
inserted gene. It acts as control for unspecific effects resulting from viral infection.
Chick embryo fibroblast and concentrated viral stocks were prepared as previously
described by Fakete and Cepko (Fekete and Cepko, 1993). Viral titers ranged from
2x108 to 109. Fertilized Hubbard broiler hen eggs, containing endogenous retrovirus
were incubated at 37°C for 1.5 days. Concentrated viral supernatant was
electroporated in ovo by Cairine Logan (Canada) on the top of the neuroepithelium at
HH stages 8-10 at the left side using two electrodes (4 mm apart). A pulse of 25
Volts, for 25 msec, was charged 6-10 times with 1 s intervals. Animals were
harvested and allowed to develop until a specific stage, at which they were dissected
and fixed by immersion with 4%PFA for 6-12hr.
16. Image processing
All images were captured with a CoolSnap Photometrics camera through a Zeiss
Axiophot, a Leica Macrophot, or a Leica Confocal microscope and processed using
Adobe Photoshop 10.
the Cla12Nco adapter
plasmid, and further
cloned at the ClaI sites of
the retroviral vector
R C A S ( B P A )  a n d
RCAN(BPA) generating
RCAS En-1, and RCAN
En-1.  RCAN(BPA) is a
variant control vector  of
RCAS(BPA) from which
the spl ice acceptor
upstream the ClaI site has
been removed, preventing
translation of the inserted
gene.
Fig II.1 En1 overexpressing retroviral construct and
control. The mouse En-1 coding region was subcloned into
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RESULTS
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1. Cell autonomous requirement of En1/2 in the midbrain DA neurons
1-1. The midbrain DA neurons are induced in the En-1/2-/-, but fail to
survive
En-1 and En-2, are two homeodomain transcription factors, involved early during
embryogenesis in regionalization (Hidalgo, 1996; Joyner, 1996), and later in the
specification of neuronal phenotypes (Lundell and Hirsh, 1998; Simon et al., 2001).
In mammals the engrailed genes are both expressed in a domain spanning the
posterior midbrain and anterior hindbrain. The domain involves part of the neural tube
generating dorsal structure, such as cerebellum and culliculi, as well as ventral
midbrain nuclei including the midbrain dopaminergic neurons. The two transcription
factors have overlapping domain and redundant function so that one (En-2) can
functionally replace the other (En-1)(Hanks et al., 1998). At birth, both single mutant
for En-1 and En-2 have no phenotype in respect to the mDA neurons (Simon et al.,
2001) Homologous recombinant mutant mice null for En1 and En2 show a large
deletion in the midbrain and anterior hindbrain, the mice die at birth due to the
inability to suck and no TH positive are present in the midbrain (Liu and Joyner,
2001a; Simon et al., 2001). It has been demonstrated that albeit the large deletion at
the MHB organizer in the En-1-/-, En-2-/-, mDA neurons are formed at E12 and are
identified as a TH positive cluster, in the ventral aspect of the mesencephalic flexure
(Simon et al., 2001). One notable feature of the mutants is the smaller size of the TH
domain and a lack of axonal projection in rostral direction. This is in contrast to
control littermate specimen, where the mDA neurons as soon as they are induced they
start to elongate their axons towards the basal telencephalon (Fig 1.A,A´).
Two days later, by E14, no TH positive neurons are anymore detected in the En
double mutant, while in the wild-type they continue to differentiate, reach the striatum
(Fig 1. B,B) and ,there, establish functional connections (Perrone-Capano and Di
Porzio, 2000). At P0 the whole midbrain dopaminergic system is missing, whereas the
dopaminergic neurons of the dorsal hypothalamic nucleus continue to be present
(Simon et al., 2001), further supporting the specific requirement of Engrailed in the
mDA neurons.
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Fig 1. Developmental disappearance of the midbrain
dopaminergic neurons in En1-/- En2-/- double null
mutant mice. Comparison of wild-type and engrailed
double mutant embryos (En1-/-;En2-/-) at E12 and
E14. Rostral is to the right. (A) E12
whole mount preparation of isolated
neural tube. TH-positive neurons are
located in the mesencephalic flexure
(arrow) of wild-type and mutant
embryo. The TH domain in the mutant
is smaller than the wild-type and there
are no axonal projections in rostral
direction. (B) Midsagittal sections of
E14 embryos. In the wild-type, mDA
neurons have continued to
differentiate and start to form the SNC
and VTA (arrow). In the mutant
embryos, no TH-positive cells are
detectable in the ventral midbrain.
Additionally the anlage for the
cerebellum (Cb), inferior colliculus
(IC) and superior colliculus (SC) are
absent in the mutant. Scale bars A,B =
200µm.
Fig 2. Developmental expression of bgal in mDA neurons. Immunohistochemical
TH/bgal labeling on E12 En-1 TLZ/+, En2-/- (A-C),En-1 TLZ/TLZ, En2-/- (D-F), E14 En-1
TLZ/+, En2-/- (G-I) coronal sections. At E12 in En-1 TLZ/+, En2-/- midbrain only few TH
positive cells dorsally located to the ventricle (A) express beta-gal (B), at the same stage
En-1 TLZ/TLZ, En2-/- no TH positive cell (D) express bgal (E). Two days later at E14 in
the En-1 TLZ/+, En2-/- almost all TH positive cells forming the anlage of the SN and VTA
(D) express bgal (E) with the exception of some TH positive cells located at the midline.
Scale bars A-F= 100µm
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It has been previously demonstrated that no respecification of the phenotype occurs.
No expression of the reporter gene, b-gal, which is cloned in the En-1 locus, and other
dopaminergic markers such as c-ret, GDNFRa, AADC, and Nurr-1 is detectable at P0
in the En-1 tLZ/ tLZ, En2-/- (Simon et al., 2001). Thus, since in the En double mutant
by E14 no TH expressing cells are found, it means that these cells disappear shortly
after induction.
1-2. Developmental expression of Engrailed in the mDA neurons
En expression is developmentally regulated. En-1 and En-2 genes start to be
expressed at E8 in the anterior mouse neuroectoderm as a mark a band of cells,
corresponding to the MHB. Later on development, the postmitotic mDA neurons start
to express both transcription factors and maintain their expression through out life
(Davis and Joyner, 1988; Gardner and Barald, 1991; Simon et al., 2001). The
generation of mDA neurons in the En-1 -/-,  En2-/- suggests that Engrailed is not
required for the specification of the precursor cells, but for the later postmitotic fate of
the cells. At this point we wanted to understand when En start to be expressed in the
mDA neurons and if its requirement is consistent with its developmental expression.
Since En-1 null allele was achieved by a “knock-in” strategy in which the first 71
codons were replaced by a Tau-lacZ sequence, we tracked the expression of En
during development by analyzing that of the reporter gene, b-galactosidase. E12 En-1
TLZ/+,  En2-/- and En-1 -/-,  En2-/- mice and E14 En-1 TLZ/+, En2-/- only were
analyzed as by E14 that time no mDA neurons are left in the En-1 -/-, En2-/-
mesencephalon. In the hetero at E12.5 only a few, laterally located, mDA neurons, are
positive for b-galactosidase (Fig 2). It is likely that the En expressing neurons are
those cells which first exit the cell cycle and while migrating from the ventricle to the
their final position (Kawano et al., 1995) switch on En (Fig2. A-C). At the same stage
in the En-1 TLZ/TLZ, En2-/- no mDA neuron express b-galactosidase, which indicates
that these neurons have just become postmitotic, express TH but are still to immature
to express En-1 (Fig 2.D-F). Two days later at E14 in the En-1 TLZ/+, En2-/- almost
all mDA neurons forming the anlagen of the SN and VTA are b-galactosidase
positive with the exception of some at the midline (Fig 2.G-I) and P0 when all
midbrain dopaminergic neurons express the two homeodomain transcription factors as
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illustrated in Fig I.10. This confirms that En is not required for the induction of the
mDA neurons (Simon et al., 2001) and further suggests that the expression of the En-
1 is switched on in the mDA neurons some time after the neurons have become
postmitotic. Thus it appears that En-1 requirement sets in progressively overtime in
the midbrain tissue and it is essential for the proper maturation and survival of the
midbrain dopaminergic neurons, so that, in the En-1 TLZ/TLZ, En2-/-, the neurons fail
to survive at the time when this requirement should set in.
1-3. The demise of the midbrain dopaminergic neurons occurs by apoptosis
At this point, we were interested to unravel the mechanism beyond the disappearance
of the midbrain dopaminergic neurons in the En-1 TLZ/TLZ, En2-/- where the
requirement of En was missing. Recently, growing interest has been cast on the mode
of neuronal cell death. Three mode of cell death are distinguished: apoptosis, necrosis,
and autophagy. Although still controversial, apoptosis appears to be the cell death
mechanism that leads to the progressive loss of mDA neurons in Parkinson´s disease.
Thereby we were interested to understand whether in the En double mutant, the mDA
neurons were also lost via an apoptotic mechanism, implying that the mDA neurons
undergo cell death trough a common mechanism upon different insults.
At E13, one day before complete disappearance of the mDA neurons in the in the En
double mutant embryo, very few TH positive cells are left, and most have retracted
axons, are rounded up, and bare typical signs of apoptosis as activated cysteine
protease, caspase-3, and a chromatin condensed nucleus (Fig 2.A-C). It is likely that
in absence of En, at this point, the mDA neurons are ´improperly geared´ for further
maturation and thereby activate a suicide program. Moreover we could observe
scavenger cells embracing dieing neurons (Fig3.F), which is in line with the normal
cell clearance after an apoptotic event (Yuan et al., 2003). It has been demonstrated
that the scavenging occurs also during PD, with detrimental effect for the progression
of the disease. In fact, dieing mDA neurons trigger an inflammatory response in the
surrounding microglia, the activated microglia, in turn, release cytokines and NO,
which makes the remaining cells vulnerable accelerating their demise (Hirsch et al.,
2003). This may also be the case for the En-1-/-, En2-2-/- mutant mice (Fig 1.B-B´).
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The apoptotic demise of the mDA neurons in the En-1-/-, En-2-/- raises different
hypothesis for the requirement of these two transcription factor: I. the midbrain tissue,
which in the En double mutant is missing, provides normally trophic support for this
neuronal population. II The developing telencephalon, which is not reached by the
mDA neurons in the mutant embryo, may provide also cues of trophic support III.
Ablation of the engrailed genes would deprive the mDA neurons of essential
components for their maturation and survival. We investigated all three different
possibilities.
2.  Axonal outgrowth of the mDA neurons in En-1-/-, En-2-/- mice
2-1. Engrailed does not regulate axonal outgrowth of the mDA neurons
The lack of dopaminergic projection in the En-1-/-, En-2-/- mutant embryos the mDA
neurons, and rapid cell demise to two days after induction raised the question whether
those neurons were not able to reach their target from which they could receive
trophic support (Oo et al., 2003), This possibility is though rather improbable,
considering that only by E14 the mDA neurons reach the striatum (Perrone-Capano
Fig 3. In the  En1/2-/- double mutants mice mDA neurons are lost by apoptosis and
cell are rapidly scavenged  (A-F) Coronal section of ventral midbrain of E13.5 En1-/-,
En2-/- embryo. A rounded TH-positive cell body is detectable (arrow). This cell is
positive for activated caspase-3 (arrow) and exhibits a condensed and fragmented
nucleus (arrow) revealed by DAPI staining Red frame, magnification of the pyknotic
nucleus (arrow). (D-E) Close up of a caspase-3/TH positive neuron (F) the DAPI
labeling shows that the picnotic nucleus (white arrow) of the cells is embraced by a
slice-like (red arrow) nucleus likely belonging to a macrophage scavenging the dieing
neuron.; Scale bars A-C and D-F Close up = 50µm
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and di Porzio, 1996), and mDA neurons are already lost at this at this age in the En-1-
/-, En-2-/-. It remained, however, possible that Engrailed was regulating the ability of
the mDA neurons to extend an axon and the lack of projections may have deprived
the cells of local survival support leading, thus, to neuronal degeneration.
As soon as the mDA neurons are induced, they grow out extensions from the cell
body by polymerization of tubulin in microtubule, which protrude progressively in
rostral direction by responding to short-range guiding molecules, and interact with
receptors present on the surface of their growth cone. These local cues are represented
by the extracellular matrix protein (ECM) laminin and fibronectin and tenascin
(Lander, 1987), permissive and non permissive glycosamminoglycans (Cavalcante et
al., 1996; Mace et al., 2002), astrocytes secreted factors (Johansson and Stromberg,
2002), and membrane bound molecules that can be cleaved and act a soluble signal as
L1 (Walsh and Doherty, 1997). En is an essential patterning gene for the midbrain-
hindbrain region and it possible that ablation of the two transcription factors leads to a
reorganization of the midbrain matrix. In such a case, the absence of any axonal
outgrowth in the mDA neurons of the En-1-/-, En-2-/- mice may result from the lack
of local permissive cues. In addition there is evidence that engrailed is directly
involved in axonal pathfinding and guidance of interneurons in vertebrate spinal cord
(Saueressig et al., 1999) and Drosophila CNS (Siegler and Jia, 1999). Specifically, in
Drosophila, it has been demonstrated that engrailed negatively regulate expression of
the cell adhesion molecules, Connectin and Neuroglian, in interneurons. If this occurs
also in mammals it is likely that En is responsible for the ability of the mDA neurons
to extend an axon. In order to investigate whether En genes are essential for the
axonal outgrowth of mDA neurons, we cultured mutant ventral midbrain onto
different permissive substrate such as 3-D collagen matrix, glass coverslips coated
with laminin or membrane vesicles derived from E12 wild-type midbrain
(Wizenmann et al., 1993). In all three conditions, the mutant TH positive had
developed processes, with a similar cytoskeletal pattern to the littermate controls (Fig
4.A-C, A´C´). Moreover the En-1-/-, En-2-/- mDA neurons, cultured on
PORN/laminin coated coverslips, showed a normal pattern for a;b-tubulin (Fig 5.D-
F) in comparison to the control littermate culture (Fig 5.A-C), suggesting thereby a
normal cytoskeletal organization of the En double mutant dopaminergic fibers.
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Fig 4. En-1-/- En2-/- mDA neurons have the ability to project an axon if cultured on
permissive substrate. Dissociated E12 ventral midbrain of control (mixture of En1+/-, En2-/-
or En2-/-) and En double mutant in 3D collagen matrix (A), on cover slips coated with laminin
(B) and a membrane carpet derived from wild-type E12 midbrain (C) after 1 day in culture
stained against TH. For the first 24h in vitro, dissociated En double mutant mDA neurons (A-
B) are viable and extend axonal processes similarly to the control culture (A´-C´). (D) The
mean length of the TH positive processes was the same for mutant and littermate controls. The
difference was not statistically significant (Student’s t-Test, p=0.35). Error bars are not shown,
since axonal outgrowth varied between 0.3 and 78µm.
Fig 5. En-1-/- En2-/- mDA neurons have a pattern of a ;b-
tubulin expression comparable to the control littermate DA
neurons. Confocal images of dissociated E12 of control littermate
(mixture of En1+/-, En2-/- or En2-/-) (A-C) and En1-/-, En2-/-
ventral midbrain (D- F) plated on polyornithine/laminin coated
coverslips  after 1 day
in culture, stained
against TH and
a ;b-tubulin. The TH
positive fibers of the
mDA neurons, from
both Control (A) and
En double mutant (D)
ven t ra l  midbra in
cultures,  show a
comparable staining
for a;b-tubulin (B, E
respectively)
indicating that both
cultured mDA neurons
are capable ofactive
microtubule
polimerization in their
processes extensions.
Scale bar= 63µM
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The extension of the mDA neurons were measured on captured layers of En-1-/-, En-
2-/- and control littermate ventral midbrain cultured on PORN/laminin coated
coverslips, since a bi-dimensional view was more appropriate for the measurement.
The axonal extension resulted of the same length of the controls littermate (Fig 4.D).
Despite this primary differentiation in vitro, under all conditions, after 72 hours the
En-1-/-, En-2-/- mDA neurons were lost completely whereas control littermate mDA
neurons were still viable and continued to differentiate in vitro (data not shown).
By tracking the number of surviving cells over time, we established that the En
double mutant cells were starting to disappear 24 after plating with a delay in
comparison to the in vivo condition, probably due to a survival supporting activity of
the extracellular matrix (ECM) protein (Pixley and Cotman, 1986). The highest loss
was then detectable between the 24- 48 hours of culture (Fig 6).
These findings demonstrate that the lack of DA axonal outgrowth in En double
mutants is not due to the inability of the dopaminergic neurons to extent an axon and
that the mutant mDA neurons are viable and differentiate normally in the first 24
hours of culture. However, shortly after a requirement for the En genes sets in, the
cells are lost. From the present results it is more likely that these transcription factors
are involved in the patterning of the midbrain substratum, where normally permissive
clues to axonal extension resides. Studies in this direction are going on and aim to
Fig 6. Time course of cell death for En1/2 double mutant
mDA neurons in culture.  Average number of TH positive
En-1-/-, En-2-/- mutant
cells counted at several
time points.
 After dissociation,
disappearance of mDA
neurons was arrested for
24 hours.
Thereafter, the mutant
cells follow their in vivo
counterparts such that
almost no TH positive
cells are left 72 hours
post dissociation. N≥5
for each time point.
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unravel the composition of the midbrain glia in the En double mutants, which in the
wild-type midbrain represent the first instructury clue for the axonal outgrowth.
2-2. L1 expression is not under Engrailed regulation
Along with the studies aimed to understand the nature of the non-permissivity of the
midbrain in the En-1-/-, En-2-/-, we investigate L1 expression. L1 has multiple roles
in axonal growth and guidance (Walsh and Doherty, 1997). It is well known that L1 is
responsible for migration of the mDA neurons along the mesencephalic radial glia
(Ohyama et al., 1998), in fact L1-/- mutant mice presents an abnormal distribution of
midbrain dopaminergic neurons of the SN and VTA moreover the axons projecting
from the substantia nigra to the caudate putamen also exhibited an abnormal targeting
pattern (Demyanenko et al., 2001). In contrast Ohyama and collegues report that L1
expression was detected only on the tangential fibers along which the mDA neurons
migrate. However there is evidence that L1 is expressed from E12 on the mDA
neurons and it acts as a survival-promoting factor for this cells (Hulley et al., 1998).
Furthermore Neuroglian, a member of the immunoglobulin superfamily closely
related to the mouse adhesion molecule L1 (Bieber et al., 1989), is transcriptionally
repressed by engrailed in Drosophila, and that L1 promoter contains a consensus
DNA with high affinity for Hox 1.3, bicoid and engrailed, and that En-1 is active on
the L1 promoter in vitro (Kohl et al., 1992).
In light of these results, we hypothized that engrailed could regulate axonal outgrowth
of the postmitotic mDA neurons in rostral direction by repressing expression of the
adhesion molecule L-1. If En would acts as a repressor of L1 expression, it should be
overexpressed in the En-1-/-, En-2-/-. It could be thus speculated that perturbed
homophilic and or heterophilic interactions of this protein with resident neurons or
glia are established (Friedlander et al., 1994; Maurel et al., 1994). This might hinder
thereby the normal outgrowth of the neurites in the mesencephalic environment.
By culturing mutant and wild type littermate ventral midbrain on the permissive
substrate PORN/laminin, we observed that mDA neurons from both phenotypes were
expressing L1 with a similar pattern (Fig 7).
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The adhesion molecule on the mDA neurons is distributed along the cell membrane of
the cell body contours and along the axons length (arrows). This is in line with the
role of this adhesion molecule playing in cell-to-cell interaction and promoting and
driving axonal growth during development (Walsh and Doherty, 1997).
Thus, no differential L1 expression between the En-1-/-, En-2-/- and control mDA
neurons would speak against any direct involvement of L1 in the axonal impairment
and would argue that En is not acting as a transcriptional repressor of L1 expression
in mammals.
2-3. Differentiation of En-1-/-, En2-2- /- mDA neurons in vitro does not
prevent these cell to die by caspase-mediated apoptosis.
As shown above in the En-1-/-, En2-2- /- mDA neurons are viable by E12 and
differentiate normally, until a requirement for the En genes sets in, which then
Fig 7. Expression of the adhesion molecule L1  doesn´t change between En-1-/-, En-2-/-
mDA neurons and littermate control. Confocal images of TH/L1 labeling,, performed on 1
day in vitro  of control littermate (A-C) and En-1-/-, En-2-/- ventral midbrain culture, show a
mutant TH positive cell(A´)  wich has extended an axon similarly to the littermate
control(A), The TH positive cells  in both mutant (B) and control culture (B) bar a punctuate
staining for L1 along  the axon length and on the contours of the cell body (arrows) with no
detectable difference between mutant and control. Scale bar A-C´= 63µm
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becomes essential for their survival. In light of the evidence that in the En1/2 double
mutant programmed cell death is switched on in the mDA neurons some time after
induction, we wanted to confirm the same mode of cell death was also taking place in
vitro, sustaining the reliability of our cell culture strategy.
We chose the time range when the highest rate of cell demise was occurring (Fig 6)
and investigated for typical hallmarks of apoptosis. 48 hr after culture, we saw that in
the En-1-/-, En-2- /- ventral midbrain culture a consistent number of TH positive cells
had retracted their processes, rolled up, presented a chromatin condensed nucleus and
were positive for activated caspase-3, one of the effectors enzymes in apoptosis (Fig
8.A-C´). Thus, En-1-/-, En-2- /- dopaminergic neurons showed morphological
hallmark of apoptosis, also when placed into culture, providing evidence that a
common mechanism of cell death accounts for the demise this neuronal population
both in vivo and in vitro.
3. Engrailed is not directly involved in triggering apoptosis
At this point we wanted to understand if En was directly involved in the apoptotic
cascade, by sensing for example intracellular signal that induce apoptosis. In such a
case, according to our speculation, En silencing would derepress transcription of key
molecules involved in the apoptotic cascade, causing eventually the demise of mDA
neurons where it is normally expressed. Studies using neurotoxin as MPTP, 6-OHDA,
or Rotenone (Ungerstedt et al., 1974; Langston et al., 1983; Betarbet et al., 2000)
show a specific ablation of the mDA neurons in cultures, and recapitulate the death
process normally occurring in Parkinson’s disease. Moreover neurotoxin treatment is
associated with active transcriptional regulation driven by activation of the
Fig 8. En-1-/-, En-2-/- mDA neurons disappear by apoptosis after two days in culture. Cell
culture at about 48 hours post dissociation stained against TH (A) and activated caspase-3 (B).
Each sample was counterstained with DAPI (C) to identify cell nucleus. Mutant mDA neurons
(arrows) retracted their processes, rounded up and are positive for activated caspase-3. An
additional sign for apoptosis is the pyknotic nuclei (magnified C´). Scale bar= 64.
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transcription factor NF-kB (Cassarino et al., 2000; Blum et al., 2001; Ryu et al., 2002)
and c-Jun (Nishi, 1997). The time course of midbrain dopaminergic demise after
MPP+, 6-OHDA, and Rotenone application resembles the one of the En-1-/-, En-2- /-
mDA neurons, in fact the signs of active apoptotic process such as axon retraction,
rounding up of the cell, activation signs of active apoptotic process such as axon
retraction, rounding up of the cell, activation of the effector caspase-3 and chromatin
condensation occur already within 24 hour after treatment. This homology in the
timing and mode of programmed cell death lead us to the hypothesis that En could act
as transducer and regulate transcription of a variety of genes involved in cell fate. So
that ablation or silencing of these genes would lead to an apoptotic choice for the cell.
We used all three neurotoxin in culture following the standard operating conditions.
E12 wild-type ventral midbrain were dissected, dissociated and cultured for 3-5 days
before neurointoxication.  24 hours after treatment 50% of the mDA neurons had
undergone apoptosis process in line with what previously reported (Mochizuki et al.,
1994), in addition all the phenotypical marker En, Nurr-1 (Backman et al., 1999),
Pbx-1 (Sgado´and Simon, unpublished data), Ptx-3 (Smidt et al., 1997) and Lmx-1b
(Burbach et al., 2003) were downregulated in those cells after treatment with MPTP,
6-OHDA, or Rotenone. As an example we report here the effect of MPP+ intoxication
on the expression of transcription factor such as En, Nurr-1, Pbx-1, which are
constitutively expressed by the mDA neurons 24 hours after intoxication. mDA
neurons showed typical signs of apoptosis and lost expression of all three
phenotypical markers: En-1 (Fig 9.A-D´), Nurr-1 (Fig 9.E-H´), Pbx-1 (Fig 9.I-L´).
Moreover by fixing the cells at time points before the 24 and 48 hours we were able to
see a progressive loss of the marker in parallel with the processing of the PCD (data
not shown). This suggest that En is not specifically sensing for the insult, but that
neurointoxication profoundly impairs viability of the mDA neurons so that these cells
generally switch off transcription factors expression as a consequence of cellular
damage.
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Fig 9. MPP+ treatment leads to general downregulation of the phenotypical markers
En, Nurr-1 and Pbx-1 in mDA neurons and eventually cell death. Immunohystochemistry
using Antibody against TH (A,A´,E,E´, I,I´), En (B,B´), Nurr-1(F,F´), Pbx-1(J,J´) and
DAPI(C,C´,G,G´,M,M´). 48 hours after MPP+ intoxication TH positive cells (A´,E´,I´)
indicated by the arrows have retracted their axons, downregulated all three phenotypical
markers: En (B´),Nurr-1(F´), Pbx-1( J´) and bare condensed nuclei (C´,G´,K´). TH positive
cells from control culture (A,E,I) normally express En (B),Nurr-1 (F), Pbx-1 (J). Scale bar=
64µm
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4. The midbrain DA neurons require En-1 and En-2 cell autonomously for
their survival
The specific loss of midbrain dopaminergic neurons in the En-1 and En-2 double
knockout (1-1) at a time when En expression sets in the mDA neurons (1-2) suggested
that these transcription factors are essential for the survival of this neuronal
population. However, since En is required for the normal development of the
mesencephalic region (Wassef and Joyner, 1997), which is apparent in En-1/2 double
null mutant by the absence of the midbrain and anterior hindbrain (Liu and Joyner,
2001b), it remained open whether the midbrain environment would have any survival
promoting activity on these neurons. In case of a non cell-autonomous requirement of
the En genes, the midbrain depletion would deprive the dopaminergic neurons of
trophic support committing them to cell death, observable in the En-1-/-, En2- /-
embryo. In turn, a cell autonomous requirement of the En genes implied that these
transcription factors, themselves, support cell survival specifically in this neuronal
population, notwithstanding the environment. The cell autonomous requirement is
supported, in first line, by the evidence that En-1 and En-2 act in a gene dose effect so
that the presence of one allele for En-2  on a En1-/- background leads to an
intermediate phenotype in respect to the mDA neurons between En1-/- and En-1-/-,
En2- /- (Simon et al., 2001).
In order to address this question we tried both a in vivo´ and `in vitro´ approach.
4-1.  En-1-/-, En-2- /- chimeric mouse
We first designed a chimera mouse by injecting En double mutant stem cells into a
wild-type blastula in order to achieve an `in vivo´ mixed population of En-1-/-, En-2-
/- and wild-type cell. The animals were viable, fertile, behaved normally, and lived up
to adulthood. However at a closer sight the amount of midbrain DA neurons in the SN
and VTA were reduced, consistently with the degree of chimerism (Thuret S. Ph.D
Thesis, 2002). In order to expand the number of animal and confirm this first result
obtained, we tried to derive stem cells from blastocysts of all phenotypes: En-1-/-, En-
2- /-, En-1+/-, En-2- /- and En-2- /-. The embryos were obtained from mating
between En-1+/-En2-/- and En2-/- mice. Thirty E3.5 blastocysts were placed onto
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feeder layers of mouse embryonic fibroblast, and allowed to grow until an internal
cell mass (ICM) had formed. More than 30% of the blastocysts gave rise to ICMs,
which were then removed, carefully disaggregated to single cells and replated onto
fresh feeder layers to allow formation of cell colonies. Unfortunately all the ICM-
derived colonies after 4 days of culture were differentiated, which can be explained
by the C57BL/6 background. Notoriously C57BL/6 ES cells are more difficult to
maintain in culture since they tend to differentiate and easily loose their ability to
colonize the germline (Auerbach et al., 2000; Schuster-Gossler et al., 2001). Thus, it
is a standard procedure by deriving ES cells to superovulate the mother, which
increases by 5 to 7 folds the number of blastocysts available. Moreover in order to
restrict C57BL/6 ES cells differentiation it may have been appropriate in our case to
use an inhibitor for ERK signaling, PD098059, which has previously been used to
inhibit differentiation and enhance self renewal of stem cells (Burdon et al., 1999).
ERKs are known to be involved in S/G1 transition and in part through the induction
of cyclin D (Lavoie et al., 1996; Weber et al., 1997) and differentiation of ES cells is
associated with G1 cyclin expression (Savatier et al., 1996), therefore inhibiting the
transition to G1 would maintain the C57BL/6 ES cells in a undifferentiated stage,
thereby increasing the yield of stem cell colonies.
In order to overcome all the evident disadvantages encountered in raising C57BL/6
stem cells, we are now bringing the En-1+/-En2-/- onto a 129 background. Having
En-1-/-, En-2- /- 129 ES cells available would be a valuable tool for further genetic
manipulation such as overexpression studies i.e. Bcl-2 (Martinou et al.,
1994)(Martinou et al., 1994), or dopaminergic differentiation strategies (Hynes and
Rosenthal, 2000; Kim et al., 2002).
4-2. Chimeric En-1-/-, En-2- /- ventral midbrain culture
In parallel to our stem cell derivation attempt we set up a “chimeric system” in cell
culture by culturing dissociated En-2- /- and En-1-/-, En-2- /- mutant ventral midbrain
together with wild- type ventral midbrain. To distinguish between the mutant and
control wild-type midbrain dopaminergic neurons we injected the pregnant En-1+/-,
En-2- /- mice with 5-bromodeoxyuridine (BrdU), and derived wild-type ventral
midbrain tissue from unlabelled NMR2 embryos. BrdU is a thymidine analogue and is
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incorporated into newly synthesized strand of DNA (Boccadoro et al., 1986). This
compound is commonly used as kinetic marker for cell proliferation, and visualized
by counterstaining using specific antibodies (Gratzner, 1982; Boccadoro et al., 1986).
In order to obtain an homogenous BrdU labeling of the mesencephalic tissue we pulse
injected En-1+/-, En-2- /- pregnant females from E10-E12, at the time when the last
mitotic event is occurring in the mDA neurons, until more than 90% of the cells were
labeled (Fig 12. A-C). The ventral midbrain from the BrdU and untreated E12
embryos were dissected, En-1-/-, En-2- /- mutant, control littermate, and untreated
control ventral midbrain were dissociated separately to single cell suspension, and
counted. 150.000 cells were plated per coverslip as homogenetic culture, BrdU
labeled En-1-/-, En-2- /- ventral midbrain alone, or heterogenetic culture, a mixture of
BrdU labeled En-1-/-, En-2- /- and wild type untreated ventral midbrain (50: 50) (Fig
10).
In both heterogenetic and isogenetic culture the En-1-/-, En-2- /- mutant DA neurons,
expressing TH and BrdU, start to die with a delay of 24 hours of culture, since plated
on PORN/laminin substrate, and entirely lost at 72 hours (Fig 11.D-F). The viability
of the DA neurons in the BrdU labeled littermate controls remained, in contrast,
almost unchanged, showing that the BrdU labeling had no unspecific toxic effect on
mDA neurons (Fig 12).
Fig 10. Cartoon depicting co-culture experiment of En-1-/- En2-/- mutant cells (green)
mixed with wild-type (pink): ventral midbrain containing the dopaminergic neurons (red)
was dissected from En-1-/- En2-/- mutant and wild-type E12 embryos. The tissue pieces were
trypsinated, the cells dissociated, their numbers counted, then plated on polyornithin/ laminin
coated cover slips and cultured for up to 72 hour. The experiments were done with wild-type,
mutant or a mixture of both. We determine the number of tyrosine hydroxylase positive cells
at 1 hour, 24 hours and after 72 hours. Mutant mDA neurons fail to survive after three days in
culture. Mutant cells were labeled by twice daily interperitoneal injections of BrdU from E9.5
–E12 to differentiate them from wild-type cells.
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The two chimeric experiments, " in vivo" and " in vitro ", reveal that no
environmental factor can rescue this cell population when ablated of En expression
and strongly support that En-1 and En-2 are cell autonomously required in the
midbrain DA neurons, and that the onset of En expression is essential for the proper
maturation and maintenance of this neuronal population.
Fig 11. En1-/-, En2 -/- mDA neurons are lost both in heterotypic,
and homotypic cultures after 3 d.i.v. . (A-C) 1 hour after plating,
almost all cells, including TH-positive neurons (arrow) derived from
En1/2-/- mutants were positive for BrdU (Red), after multiple
intraperitoneal BrdU
i n j e c t i o n s  ( C )
Example of double
labeled (TH=green,
BrdU=red). (D-F)
After three days
in the mixture of En
double mutant and
control littermate
ventral midbrain,
only single labeled
TH neurons and no
TH-positive, BrdU-
labeled cells were
present in culture.
Scale bars = 20µm
 (En1+/-;En2 -/- ) and
homozygote (En2-/-) BrdU
labeled cells. In control case,
number of mDA neurons
decreased only slightly
between 24 hours and 72
hours. Regardless, whether
mutant En1-/-;En2 -/- cells
were mixed with wild-type or
cultured on their own, the
numbers of TH-positive cells
derived from engrailed double
mutants decreased almost to
zero after 72h from a baseline
of in average 45 TH-positive
mutant cells at 24h. n≥12 for
each bar, (Student’s t-Test,
p<0.001)
Fig 12. Quantification of En1-/-, En2 -/- mDA neurons
demise in heterotypic, and homotypic cultures. Numerical
charts show the  average number of TH positive cells after 24
hr hr and 72 hr in vitro: Control, mixture of heterozygote
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5. RNA interference of En-1 leads to disappearance of the mDA neurons
with En2-/- background
Despite the initial differentiation of mDA neurons from En-1-/- En2-/- mutant E12
mice, when placed into culture, it remained open whether those cells were already
committed to cell death before the tissue was dissociated, in that case the selective
loss of the mutant mDA neurons in the mixture experiment would therefore reflect
this early commitment.
To address this possibility, we took advantage of RNA interference (RNAi), which
allows post-transcriptional gene silencing both in vivo and in vitro. This biological
mechanism was first discovered in the nematode worm Caenorhabiditis elegans (Fire
et al., 1998) but is present in many other organisms such as Drosophila, plants and
protozoans (Hammond et al., 2001). The proposed mechanism involves cleavage
dsRNAs by ribonuclease into 21-22 nucleotide RNA duplexes or small interfering
RNAs (siRNA). These molecules trigger degradation of the cognate mRNA (Zamore
et al., 2000; Bernstein et al., 2001). Recent experiment have shown that the
application of small interfering RNA duplexes (siRNA), of 21 nucleotides in length,
leads to specific m RNA degradation in mammalian cell lines (Elbashir et al., 2001)
and primary cell culture (Krichevsky and Kosik, 2002). Applying the rules proposed
by Elbashir S.M. (Elbashir et al., 2002) we constructed 21 nucleotides primers for En-
1, and control oligos, such as lamin A/C, a nuclear protein often used as a standard
control (Elbashir et al., 2001), scrambled oligos, generated by a random process, and
Pbx-1, another homeobox transcription factor expressed by the mDA neurons (Sgado
P. and Simon H.H. unpublished data). We then transfected the siEn-1, and the control
oligos into ventral midbrain culture of homozygous null mutant mice for En-2, since
the En-2-/- do not exhibit any phenotype in respect to the mDA neurons (Simon et al.,
2001). After isolation and dissociation of the E12 ventral midbrain, cells were plated
onto PORN/laminin coated coverslips, let for 3 days into culture and then transfected
using siRNA oligos duplexes at a concentration of 0,003-0,03µg/ml per well. All
oligos were applied at this concentration range in order to avoid any off-target effect
(Jackson et al., 2003). At the third day in culture, the mDA neurons show a complex
network of neurites and all express En-1 and Pbx-1. Already 12 hours after
transfection the first En-1 negative DA neurons were detected, but the number of TH
positive cells remained unchanged (Fig 13.B).
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The first signs of apoptosis and cell loss were detectable at 24 hours, reaching a peak
at 48 hours, when the highest amount of En-1 negative mDA neurons was detected
(13% of the control). During the following 48 hours the number of TH positive cells
progressively declined to 75% and at 96 hours stabilized, when no more En-1
negative DA neurons were visible (Fig 13.B). In the control transfection no alteration
in cell viability was detected (Fig 13.A), and the degree of silencing (12%) of the
control marker Pbx-1 resembled the one of En-1 (Fig 15.D). Dieing En-1 negative
mDA neurons, in the En-1 interfered En2-/- cultures, showed specific hallmarks of
apoptosis, neurites retraction, rounded body, activated caspase-3 and chromatin
condensation (Fig 14.A´-D; E-H). In contrast all control cultures, mock transfected
(Fig 14.A-D), Pbx-1, lamin A/C interfered cultures (Fig 15.A-C) were normal in all
aspects we investigated. The experiment shows thereby that switching off En-1
expression in En-2-/- mDA neurons affects deeply the viability of these neurons,
committing them to a suicide program.
 Fig 13. Effect of RNA interference
on primary cell cultures derived
from En2-/- ventral midbrain. (A)
Numerical chart of RNA interference
normalized against mock-transfected
control. Only the transfection with
En1-specific siRNA oligo duplexes
reduced the numbers of TH-positive
cells after 96 hours. n≥ 10 for each
transfection. (Student’s t-Test p=0.001
for mock control versus En1
transfection) (B) Time course for the
loss of mDA neurons after
transfection with E n 1  oligos
normalized against mock-transfected
controls. Twelve hours after
transfection, there were no changes in
the numbers of TH-positive neurons,
however a significant proportion of
En1  negative cells were present.
Number of TH-positive cells
gradually decreased until 96 hours
when the amount of DA neurons
stabilized. Maximum amount of TH-
positive and En1-negative cells was
detectable at 48 hours.
  B
A
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(A-B) 48 hours after transfection with Pbx1
specific RNA duplexes, Pbx1  expression is
silenced in some mDA neurons (arrow) but is
preserved in the majority (double arrow head).
Regardless of Pbx1  expression, the cells
maintained their processes and the shapes of
their cell bodies. (D) Data graph showing the
degree of silencing 48 hours after transfection
with Pbx1  and En1 specific RNA oligos. A
comparable proportion of TH positive cells,
12%, are negative for P b x 1  and E n 1 ,
respectively. The number of TH-positive cells is
, although, only reduced after siEn1 transfection.
Scale bar A-C = 20µm.
Fig 14. En-1 siRNA applied to En2-/- ventral midbrain culture impair survival of the
mDA neurons inducing them to undergo apoptosis (A-D) Immunohistochemistry on En1
transfected cultures after 48 hours. The transfected TH positive cell (arrow) was round, had no
processes, was En1 negative (red) and possessed a fragmented, pyknotic nucleus (DAPI). (A’-
D’) The mock-transfected control cells (double arrow head) maintained their neurites and
were En1-positive. (D) Magnification of DAPI staining in C. (E-H) Confocal images of En1
transfected culture. Three TH-positive neurons are present in this field; one (arrow) had a
rounded cell body, was En1-negative and stained positive for activated caspase-3 (blue). Two
others (double arrowhead) had spindle shaped cell bodies with attached neurites, were En1-
positive and caspase-3 negative. Scale bar A-H = 20µm, D = 10µm
Fig 15. RNA i
using a siPbx
ablates specific
genes expression
but is dispensable
for survival of the
mDA neurons..
D
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This resembles the cell fate of the En-1-/- En2-/- mDA neurons and indicates that the
lack of any rescue effect of the wild-type environment on the En-1/2 mutant mDA
neurons in the cell mixing experiment it is not an artifact of a previous commitment of
this neuronal population.
The result from the RNAi experiment, thereby, provides further evidence of the cell
autonomous requirement of the En transcription factor in the survival of midbrain DA
neurons.
 6. Rescue of double mutant DA neurons by caspase inhibition
As from our "in vitro" and  "in vivo" studies it was evident that the mDA neurons
demise is occurring via apoptosis, interference with this pathway could results in a
rescue of the mDA neurons.  Previously, it has been reported that synthetic caspase
inhibitors, such as Boc-(Asp)-fluoromethylketone(BAF) under 6-OHDA intoxication
(Lotharius et al., 1999), and N-benzyloxycarbonyl-Val-Ala-Asp-fluoromethyketone
(zVAD-fmk,) under MPP+ intoxication (Bilsland et al., 2002) had a protective effect
on mDA neurons in culture by preventing cell death (50-70% recovery in both cases).
Despite the significant recovery of mDA neurons viability, only partial restoration of
neural projection, and [3H]DA uptake (Dodel et al., 1998; Bilsland et al., 2002) was
observed. The rescue effect of the caspase inhibitors remains yet contradictory as
Hartmann et al. (2001) report that addition of zVAD-fmk to MPP+ treated cultures
potentiate the toxicity against mDA neurons by increasing necrosis.
We used the caspase inhibitor, zVAD-fmk, in the concentration where more than 50%
recovery was observed, and applied it to the double mutant ventral midbrain culture 6
hr after plating, and let it for 72 hr in culture, at the point when cultures were fixed.
From our experiment no recovery of mDA neurons in the En-1-/-, En-2-/- ventral
midbrain culture could be detected (Fig 16), moreover we observed that in our treated
control culture, the inhibitor zVAD-fmk exerted a toxic effect on the viability of the
mDA neurons, confirming the toxic effect of the general caspase inhibitor observed
by Hartmann et al, 2001.
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In turn, the application of DMSO alone was able to slightly rescue the double mutant
mDA neurons, whereas control culture remained unchanged. This can be explained
alteration in the Ca2+ intracellular stores, as a result of membrane solubilization by
DMSO, which can lead to temporary enhanced survival (Orrenius et al., 2003). The
result has to be confirmed by applying depolarizing conditions (Yu and Chuang,
1997) that enhance the intracellular Ca2+ content that would reveal an active
involvement of Ca2+ in the survival/death program in this system.
7. En-1 regulates p75 transcription
7-1. En-1 is transcriptionally repressing p75 expression
A tetracycline inducible cell line overexpressing En-1 has been established in the lab.
Gene expression profiling was performed using the cell line upon induction with
Doxyclyline, and as a control the same non-induced cell clone. Microarray analysis
from En-1 overexpression in a Neuro2A Tet-on cell lines, revealed that Engrailed is
regulating p53 and p75. Interestingly enough both molecules are involved directly in
neuronal cell death. p53 is a cell sensor component activated by the nuclear enzyme
poly (ADP-ribose) polymerase (PARP) following DNA damage or ROS release.
MPTP intoxicated mice show a strong poly ADP-ribosylation of p53 from PARP in
the brain (Mandir et al., 2002), and there is evidence that p53 protein is necessary for
Fig 16. Avarage amount of TH+ cells
under treatment with the caspase
inhibitor zVADfmk after 3 days of
culture. Data graph shows the effect of
the general caspase inhibitor zVMAD-
fmk on the viability of the En-1-/-, En-
2-/-  and control littermate mDA
neurons (Wt). The inhibitor has no
rescue effect on the mDA neurons of
the En-1-/-, En-2-/-, in turn, it results
toxic to the control culture. Control
culture with addition of an equivalent
amount of DMSO show a slight rescue
effect on the mutant En-1-/-, En-2-/-
culture however, whereas it has no
effect in the control wild-type culture
n≥ 5 for each bar.
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complete expression of MPTP neurotoxicity to dopamine neurons since p53-/- null
mice result partially resistant to MPTP intoxication (Trimmer et al., 1996).
p75NTR, on the other hand, is the low-affinity neurotrophin receptor. Recent
evidence suggested a role for p75(NGFR) in developmentally regulated neuronal cell
death of sympathetic neurons at the time when the ratio of p75 and TrkA is in favor of
p75, and neurotrophin dependence is higher. Moreover Schwann cell isolated from
p75-/- null mice (Syroid et al., 2000) or sensory neurons and hyppocampal neurons
treated with p75 blocking antibodies are resistant to NGF mediated apoptosis (Davey
and Davies, 1998; Friedman, 2000). More recently it was reported, antibody directed
against the extracellular domain of murine p75(NTR), activate the receptor and
profoundly effects the survival of short-term cultures of sympathetic neurons (Freidin,
2001).
 In light of the results emerging from the Microarray analysis and from the cell
autonomous requirement for En in the mDA neurons, we wanted to know if in the En-
1-/-, En-2-/- double null mice upregulation of these proteins occurs. For this purpose,
we performed quantitative expression analysis by Real-Time PCR, using Assays on
Demand (Applied Biosystem) for the murine p53 and p75, on embryonic ventral
midbrain from En-1-/-, En-2-/- mice and control littermate, and as a control the cell
line overexpressing En1 with or without doxicycline induction. Since no FACS sorter,
to select mDA neurons, is available in our lab, and it appears that the total yield of
neurons from embryonic tissue is rather poor (Barrett et al., 2001) we carefully
dissected E12 ventral midbrain in a butterfly-like shape, where mDA neurons are
located, and extracted RNA from the tissue pieces. We quantitatively analyzed the
gene expression in the tissue at E12.5 at the time when the mDA neurons are present.
From the quantitative analysis it appears that p53 expression remains unchanged
either between the two engrailed phenotypes or the two cell lines (data not shown).
p75(NTR) expression, in turn, results by three fold increased in the En-1-/- En-2-/-
mice is in respect to the control (mixed population of E12 En-1+/- En-2-/- and En-2-/-
ventral midbrain) On the other side, as it would be expected, p75 expression is
consistent downregulated in the inducted cell line overexpressing En-1 in comparison
to the non-inducted control (Fig 17).
These results suggest that engrailed regulates the expression of p75 (NTR) in the
midbrain, where the transcription factor is constitutively expressed, and that the
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ablation of this transcription factor may lead to a receptor overexpression.
Overexpression of p75 may, thus, override the balanced ratio between low affinity
receptor to the high affinity receptor Trk, thereby rapidly triggering either
neurotrophin-induced apoptosis, or stress-induced cell death (Barrett, 2000) in the
neurons located in the midbrain including the dopaminergic neurons.
7-2. The p75(NTR) promoter contains consensus sequence for the
homeodomain transcription factor engrailed
Another strong evidence for the regulation of p75 (NTR) by En-1 arise from the
BLAST search and Mat-Inspector V2.2 analysis for high affinity binding sequence for
the homeodomain transcription factor En, consensus sequence, in the mouse and
human p75 promoter region. The analysis revealed that the p75 promoter contains two
highly matching consensus sequences for the homeodomain transcription factor
between –140-180bp and  –250-340bp from the start codon for the Drosophila
engrailed and the mammalian En, respectively (Fig 18), and that this region is
strongly conserved between the two species (>98% homology). This suggests that En
constitutively regulates the expression of p75(NTR) by transcriptionally repressing its
expression. This is consistent with the classical role of Engrailed as a transcriptional
repressor, as previously shown, for adhesion molecule connectin and neuroglian in
spinal interneurons in Drosophila (Siegler and Jia, 1999) and diencephalic gene Pax-6
in mammals (Araki and Nakamura, 1999).
Fig 17. Quantitative  p75 expression in N2AEn-1 cell line, non -
induced control and E12.5 ventral midbrain of En-1-/- En-2-/-
and En-1+/- En-2-/-.
Data graph show on the
left the drastic down
regulat ion of  p75
expression in En-1 N2A
cell line in comparison
to the non-induced
control, and that  in the
En1-/-, En-2-/- E 1 2 . 5
ventral midbrain  there is
a three fold increase in
p 7 5  e x p r e s s i o n
compared  to the control
En-1+/-, En-2-/- ventral
midbrain tissue.
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In addition, taking into account that the mode of and timing of cell death recapitulates
the one observed in p75 mediated demise of sympathetic neurons (Freidin, 2001) and
sensory neurons (Majdan et al., 1997). The present result further proposes that indeed
in En-1-/-, En-2-/- over-expression of the p75 receptor may mediate apoptosis in the
midbrain dopaminergic neurons.
8.  En-1 overexpression in the chick
As previously demonstrated, the domain of the midbrain dopaminergic neurons in the
En-1-/, En-2-/- E12 embryo is significantly smaller than the control littermate (Simon
et al., 2001). This reduction could be explained by a regionalization deficit occurring
in the En1/2-/- double null mutant embryo (Liu and Joyner, 2001b). Since one of the
En function is to maintain midbrain identity, as shown, by negatively regulating
repressors of mesencephalon-related genes (Wurst et al., 1994; Araki and Nakamura,
1999; Scholpp and Brand, 2001). Alternatively, it is possible that the number of
midbrain dopaminergic precursors formed in the En-1-/-, En-2-/- embryo is
comparable to the wild-type, but individual cells at different stages of maturity are
observed, suggesting that the cell autonomous requirement for En may interest only a
subset of the same population, differentiating progressively overtime. This is in line
with the differentiation time course of mDA neurons in the mice, where the first
postmitotic cells are detectable by E10 (Kawano et al., 1995), and fits with the
progressive onset of En expression in the midbrain (Fig 8). Thus, when the first cell
disappear in the midbrain of the En-1-/, En-2-/-, other cells are either just been born,
or in an earlier differentiation stage when En is not yet required. To differentiate
Fig 18. The p75 promoter contains two highly matching consensus sequence for Engrailed.
Schematic representation of the Mat-Inspector analysis of promoter region for the mouse and
human p75 (98% homology within the two) shows that between –140-180 and –250-340 there are
respectively two highly matching binding site for the Drosophila engrailed, and the mammalian
En-1, respectively. Revealing a direct transcriptional regulation of the homeodomain transcription
factor on p75 expression.
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between these two possibilities a gain of function experiment on the chick embryo
was performed. If the En genes determine the size of the competent mesencephalic
tissue that can adopt a dopaminergic phenotype, by enlarging the expression domain
of En-1 an increase in number of precursor cells and subsequently of mDA neurons
should be observed. The En genes specify the midbrain and anterior hindbrain, from
around stage 8 to 11 in the chick embryo (Araki and Nakamura, 1999). Chick
embryos of this age were electroporated on one site using a non-competent retroviral
vector RCASEn1 envA. This construct contains a mouse En-1 c-DNA (Joyner and
Martin, 1987; Logan et al., 1992) flanked by two LTR sites of the RCASBP(A)
(Hughes et al., 1987). To ensure that the infection of RCASBP does not induce, itself,
any transformation in the chick brain, a mock electroporation was performed using
RCANEn1 (Logan et al., 1996), this retroviral isoform lacks the splice acceptor site
required for proper translation of En  protein. The plasmid (RCASEn1) was
electroporated in the developing neural tube at one side at Hamburger Hamilton (HH)
stage 8-10 in ovo (Logan et al., 1996). This stage correspond to the mouse E8. At this
time the progenitor cells are still uncomitted to a specific phenotype, and En is
transiently overexpressed in a region where it is, normally, absent (Ye et al., 1998).
En-1 overexpression was detected by whole mount RNA in situ hybridization, and
distinguished from endogenous En-1 expression using a mouse specific probe. 2
RCASEn1 envA electroporated, HHS 8-10, chick embryos showed a strong staining
for the mouse En-1 transcript, whereas the 2 mock electroparated controls showed no
staining at all (data not shown).
8 RCASEn1 electroporated, E7, chick specimens, and 1 mock control, were analyzed.
7 of the RCASEn1 electroporated chicken showed no alteration in the amount of
mDA neurons in respect to the mock control and unelectroporated side. Only in one
single brain we see a decrease in the total amount of TH positive cells, accompained
by a tectal shrinkage at the electroporated side (Fig 19.A, A´). This latter example can
be interpreted as a developmental impairement of the tissue due to a toxic effect of the
plasmid.
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Thus, from our results it appears that transient En-1 overexpression acts only as a
regionalization factor of the midbrain  and it has no influence on the specification of
the competent tissue, that will give rise to dopaminergic neurons. It remains however
open whether the specification of the dopaminergic phenotype does not require the
cooperation of both transcription factors En-1 and En-2.
Fig 19.  mouse En-1 overexpression on the left side of the chick midbrain. TH
immunostaining on a coronal section of infected chick with the retroviral vector
RCASEn-1(A-A´). The chick specimen shows no change in the number of mDA
neurons on the RCASEn-1 electroporated side (arrow), in respect to the control side,
close up (A´). Scale bars (A-B)= 8µm (A-B´)= 200µm.
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The molecular mechanisms responsible for the maintenance and survival of mDA
neurons are just beginning to be unraveled. Here, I demonstrated that En genes are
cell-autonomously required for the survival of mDA neurons and that the ablation of
En expression induces apoptotic cell death. In addition I propose that the mechanism
leading to neuronal cell death is due to overexpression of the low affinity
neurotrophin receptor and death receptor p75.
I. mDA neurons undergo apoptosis when ablated of En-1 and En-2
expression.
En-1 and En-2 are expressed at the mid-and hindbrain boundary (Joyner, 1996),
including the mDA from development onwards (Simon et al., 2001). Ablation of both
transcription factor leads to a large deletion of the dorsal midbrain structure including
the isthmus, the main source of Fgf-8 in the midbrain (Liu and Joyner, 2001b).
Midbrain dopaminergic neurons are induced at the right position, express the
postmitotic marker TH (Simon et al., 2001), but two days later, at E14, diappear. Here
I demonstrate that En expression is switched on progressively in the mDA neurons, so
that at E12 only few cells express it and by E14 all do. Since in the En-1 -/- En-2-/-
embryo mDA neurons are completely lost at E14, at the time, when En expression
should set in, it is suggestive that En is essential for the survival and further
differentiation of this neuronal population. There are several null mutations of
transcription factors that lead to the prenatal loss of mDA neurons. In homologous
recombinant mutant mice for Nurr-1 (Zetterström et al., 1997; Wang et al., 2003),
mDA neurons fail to express their neurotransmitter phenotype and begin to disappear
at E15 (Wallen et al., 1999). The aphakia mice, a spontaneous null mutation of Pitx3,
(Semina et al., 2000) exhibit a specific loss of nigral DA neurons (Nunes et al., 2003;
Van Den Munckhof et al., 2003). In null mutants for Lmx1b, the entire population of
mDA neurons is lost by E17 (Smidt et al., 2000). Furthermore, the null mutation for
the trophic factor TGFa (Blum, 1998) leads to a reduction of DA neurons in the SNpc.
The differential time courses, and the different degrees of neuronal loss, suggest that
the molecular bases for the reduction in each of the mutant strains are unrelated. In
this context, the En double mutant phenotype is of particular interest since the mDA
neurons disappear as early as E14.5 and the entire dopaminergic population is
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affected. En is, therefore, dispensable for the induction of the mDA neurons (Simon et
al., 2001), however it seems to indirectly affect the size of the competent progenitor
tissue. Indeed the shrinkage of the TH domain observable in the En-1/2 double mutant
mice at E12 may result from the narrowing of the Fgf-8 domain to a small patch,
located in the dorsal midbrain (Liu and Joyner, 2001b).
Since it has been previously demonstrated that the loss of the TH positive neuron in
the En-1 -/- En-2-/- is not a consequence of a respecification of the neurotransmitter
phenotype (Simon et al., 2001), the survival impairment of this neuronal population
can be addressed to an essential requirement of En for the proper survival and
development of these neurons. At this point it was essential to understand what
mechanism underlies the dopaminergic cell demise and thereby unravel the molecular
cause of the survival failure under En ablation. Three principle mechanisms for
neuronal cell death have been described, namely apoptosis, necrosis, and autophagy
(Pettmann and Henderson, 1998). Here we demonstrated that only few TH positive
cells were left one day after induction (E13) in the midbrain of double null embryo,
and that 30% of them bare specific hallmark of apoptosis, such as cell shrinkage,
caspase-3 activation, and pyknotic nuclei. Those morphological signs of programmed
cell death in mDA neurons of the En-1 -/- En-2-/- mice recapitulate the apoptotic
profiles in the mDA neurons of other null mutant mice such as the Nurr1-/- (Saucedo-
Cardenas et al., 1998; Wallen et al., 1999), the aphakia (Van Den Munckhof et al.,
2003) and Lmx.-1b mice (Smidt et al., 2000). Evidence for programmed cell death
involving the mDA neurons has been confirmed in many different experimental
models for PD, following injury striatal excitotoxic injury (Macaya et al., 1994) or
treatment with specific neurotoxins like MPTP (Tatton and Kish, 1997) and 6-OHDA
(He et al., 2000). Apoptosis plays also a role in the regulation of the numbers of mDA
neurons during the first 14 days after birth (Jackson-Lewis et al., 2000; Chun et al.,
2002), likely reflecting a dependency of neurons on GDNF during this period (Burke
et al., 1998; Granholm et al., 2000), Another line of evidence for apoptotic cell death
of the mDA neurons comes from the postmortem analysis of brains from PD patients
where signs of apoptosis were detected in dopaminergic neurons (Hartmann et al.,
2000). Thus programmed cell death is triggered in many different experimental
paradigms in this neuronal population, both during normal development and during
the pathological degeneration. This speak for a preferential cell death mode for the
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demise of the mDA neurons, suggesting that when these neurons are insulted and
impaired in their normal functioning or ablated of essential components, they switch
on a suicide program, which leads to their progressive demise.
II. Engrailed does not regulate axonal outgrowth of mDA neurons
Another remarkable feature of the mDA neurons in the En-1 -/- En-2-/- mouse
embryo is the lack of axonal outgrowth. This raised the possibility that En was
regulating also the ability of these neurons to project an axon. During development of
the central nervous system (CNS), neuron grow out neurites whose growing tips are
guided by growth-permissive or inhibitory molecules synthesized by non-neuronal
cell. Thus, under instruction of this guidance molecule the axons are directed in
highly selective pathway towards their target where they eventually establish specific
connection (Tessier-Lavigne and Goodman, 1996; Drescher et al., 1997b). This is also
true for the dopaminergic neurons. As soon as these neurons become postmitotic, they
start to express tyrosine hydroxylase (TH), and begin polymerization of tubulin in
microtubules to grow out axons and dendrites (Perrone-Capano and Di Porzio, 2000).
The orientation along which neurites grow is determined by ligand binding to
receptors on growth cone, which controls actin polymerization in filopodia and
lammellipodia (Tessier-Lavigne and Goodman, 1996). Midbrain dopaminergic
neurons, thereby, elongate their axons, selectively, from the ventral midline towards
the telencephalon, so that by E14.5 the nigral and ventral tegmental dopaminergic
neurons, have reached their axonal target (Perrone-Capano and di Porzio, 1996): the
dorsal striatum, nucleus accumbens and olfactory tubercule. The rostral pathfinding of
the dopaminergic projections is the final result of non-permissive and permissive local
cues distributed along the caudal- rostral path. An important group of local guiding
cues are extracellular matrix protein (ECM) such as laminin, fibronectin, tenascin and
proteoglycans (Fitch and Silver, 1997) produced by midbrain astroglia (Garcia-Abreu
et al., 1995a). In addition differential expression of glycosamminoglicans (GAGs)
confer non- permissive and permissive properties in the medial (M) and   lateral (L)
midbrain glia population respectively (Garcia-Abreu et al., 1995b; Garcia-Abreu et
al., 2000; Mendes et al., 2003). The adhesion molecule L1, moreover, has multiple
roles in axonal growth and guidance of the mDA neurons (Walsh and Doherty, 1997)
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and acts also as a survival-promoting factor for this neuronal population (Hulley et al.,
1998). In contrast netrins, which are expressed at the floor plate, mediate a repulsive
effect preventing any axonal crossover at the midline (Lumsden and Davies, 1983;
Tessier-Lavigne et al., 1988).
It has been previously reported that engrailed genes are involved in controlling axonal
pathfinding by regulating expression of adhesion molecule such as connectin and
neuroglian, homologous of the mammalian L1, in Drosophila interneurons (Siegler
and Jia, 1999), and similar adhesion molecule in cockroach sensory axons (Marie et
al., 2002).  The evidence that in the En1-/-, En2-/- E12 embryo the mDA neurons
were not projecting rostrally but bared only sparse, unidirectional, short extension,
suggested that that En may control axonal outgrowth of the dopaminergic neurons
either by regulating the expression of adhesive molecules, confirming the previous
reports or by interfering with the cytoskeletal organization of these neurons. From the
cell culture experiments using different permissive substrate such as laminin, 3D
collagen matrix, and wild type ventral midbrain vesicles, we observed that 24 hr after
plating the mutant dopaminergic neurons had extended projections of comparable
length to the wild-type and had an a,b-tubulin pattern similar to control cultures. In
addition, expression of the adhesion molecule L1 on En1-/-, En2-/- mutant mDA
neurons resulted unchanged in comparison to the littermate control culture. These
results, taken together, suggest that engrailed is not impairing the neurons in their
intrinsic ability to extend an axon neither by controlling b-tubulin polymerization, nor
by controlling the expression of the adhesion molecule, L1. In such a case it remains
the possibility that the environment depleted of En expression is lacking glial derived
permissive cues for the directional outgrowth of the neurites. This would recapitulate
the role of en genes in the grasshopper where they specify neural precursor cell to a
glial fate (Condron et al., 1994). Another component guiding the dopaminergic axons
along the posterior-anterior path is represented by the repulsive cues such as Ephrin
A2, A5 peaking at the isthmus (Cheng et al., 1995; Drescher et al., 1995; Nakamoto et
al., 1996; Drescher et al., 1997a; Frisen et al., 1998). As previously described, the
En1-/-, En2-/- mutant embryo has a large deletion of the MHB (Liu and Joyner,
2001b), in such case the repulsive-instructive activity arising from the isthmus would
be missing thereby dis-orienteering the projection of the mDA neurons in rostral
direction. In addition there is also evidence for diencephalic directional cues that
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guide the dopaminergic axons rostrally similarly to other monoaminergic neurons, i.e.
serotoninergic and noradrenergic. Those neurons reside in the hindbrain and extend
their axons rostrally along the longitudinal axis (Nakamura et al., 2000). Ablation of
engrailed, which is normally repressing diencephalic fate (Araki and Nakamura,
1999), could cause a caudal redistribution of diencephalic cues, which would impair
the primary axonal elongation in the mDA neurons. To further investigate the causes
of the projection deficit of the En-1 -/-, En-2-/- mDA neurons in vivo, I am planning
to analyze the glial profile in the En-1 -/-, En-2-/- E12.5 ventral midbrain in
comparison to control littermate by Microarray gene expression analysis. Beside, this
will provide further information on the mesencephalic molecular cues, which confer
permissive or non-permissive property to the tissue.
III. mDA neurons require En-1 and En-2 cell autonomously for their
survival
As shown by this study, the developmental disappearance of the mDA neurons in the
En-1 -/-, En-2-/- occurs synchronous to the onset of En expression, and this speaks for
a direct involvement of the En genes in the survival of the mDA neurons (Simon et
al., 2001). Nevertheless, the large morphological defect at the midbrain and
cerebellum in the En-1 -/-, En-2-/- mice (Joyner, 1996) left open the question whether
mDA neurons demise in the En double mutant was not caused by the loss of
environmental factors, normally providing trophic support to developing neurons. In
such a scenario the requirement of En would have been non cell-autonomous, whereas
in case of a cell autonomous requirement of En, the En-1 -/-, En-2-/- mDA neurons
would be lacking fundamental components supporting cell survival, regardless of the
environment. In order to address this question we performed two cell mixing
experiment both “in vivo”, and “in vitro”, where En-1 -/- En-2-/- mDA neurons were
surrounded from a wild-type environment.
In both experimental paradigms, “in vivo” and “in vitro”, we observed the same
result:  either in the chimeric mouse made up of 50% En-1 -/- En-2 and wild-type
cells, or the mixed primary mesencephalic culture, the mutant mDA neurons died in
spite of the wild-type environment. This demonstrates that E n genes are cell
autonomous required for the survival of the midbrain dopaminergic neurons and
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supports the essential role of the En genes in the maturation of the dopaminergic
neurons. In addition, the cell death time course, and mode of cell death for the En-1 -
/- En-2-/- mDA neurons “in vivo” and “in vitro” resulted the same, which allowed us
to adopt the “in vitro” paradigm to address further questions regarding the
involvement of En genes in the survival/death pathway.
 In order to understand whether En genes were directly involved in the apoptotic
pathway by functioning as cell sensor and apoptotic repressor, as it is the case for
other transcription factor such as p53 and NF-kB, we tested the effect of different
neurotoxin specific for the mDA neurons. Already 24 hours after MPP+, 6-OHDA,
and Rotenone intoxication we observed that the expression of En-1, Nurr-1, Pbx-1,
Lmx-1b, Ptx-3, expressed specifically in this neuronal population, was ablated. This
was indicating that En is not selectively silenced after cell damage, but the general
sweeping out of the transcription factor expression is rather a consequence of the
toxic insult, that leads eventually to cell death.
Since the apoptotic mode of cell death affecting the mDA neurons is extensively
studied and new strategies to target programmed cell death are being developed, we
tried to rescue En-1 -/-, En-2-/- mDA neurons by using a general inhibitor of
apoptosis, zVAD-fmk. This inhibitor has been reported to rescue mDA neurons after
MPP+ intoxication up to 80%(Bilsland et al., 2002). In our En-1 -/-, En-2-/- primary
ventral midbrain culture, however, no rescue of the mDA neurons was observed after
application of the inhibitor. Which is in line with what other authors observed, where
zVAD-fmk exerted no rescue effect on MPP+ treated ventral midbrain culture
(Hartmann et al., 2001b). Quite strikingly, in turn, the application of DMSO alone
was able to partially rescue the double mutant mDA neurons. DMSO is an organic
hydrophobic solvent, which solubilizes all type of cellular membrane, and can
possibly release intracellular stores of ions such as Ca2+. Changes in intracellular ion
homeostasis has various effect for example under depolarizing condition (K+ 20-
50mM) a moderate increase in intracellular Ca2+ is induced, thereby preventing
spontaneous cell death of midbrain dopaminergic neurons (Douhou et al., 2001),
however prolonged exposure to Ca2+ leads to activation of calpains which produces a
negative feedback loop, that blocks the rescue activity of calpains inducing plasma
membrane disruption and secondary necrosis (Neumar et al., 2003). This may explain
why some author report a shift to necrotic cell death 72 hours after application of the
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caspase inhibitor zVAD-fmk (Hartmann et al., 2001b). A large increase in
intracellular Ca2+ promotes, in turn, excitotoxic cell death (Orrenius et al., 2003). It
would be of interest to confirm the involvement of Ca2+ in the death molecular
pathway of the En-1 -/-, En-2-/- mDA neurons upon K+ depolarization in primary cell
culture. One additional approach to investigate the dynamic of apoptosis, which is
triggered by the ablation of the engrailed genes, would be inhibiting protein
translation by application of cycloheximide in En-1 -/-, En-2-/- ventral midbrain
culture. If any rescue effect would be detectable that would tell us that engrailed is
constitutively repressing key molecules involved in the apoptotic process, and that its
absence would switch their production on, triggering the cell death program.
IV. En-1 RNAi induces rapid apoptosis of En-2 -/- mDA neurons
Despite all signs of viability that the En1/2 double mutant mDA neurons showed
during the first 24 hours in culture, it was still possible that the cells were already
committed to cell death at the time of tissue dissociation. Thus, the selective loss of
mutant mDA neurons during the cell mixing experiments might only reflect this
commitment. To address this possibility, we silenced the En expression in mDA
neurons by RNA interference (RNAi). RNAi was first discovered in the nematode
worm, Caenorhabiditis elegans (Fire et al., 1998), and it is a constitutive mechanism
to regulate protein homeostasis, consisting in  degradation of the cognate mRNA by
21-22 nucleotide RNA duplexes or small interfering RNAs (siRNA) (Zamore et al.,
2000; Bernstein et al., 2001). Recent experiment have shown that the application of
synthesized small interfering RNA duplexes (siRNA), 21-22 nucleotides in length,
leads to sequence-specific mRNA degradation in cultures of mammalian cell lines
(Elbashir et al., 2001) and mammalian neurons (Krichevsky and Kosik, 2002). Also
when primary cell culture are rather resistant to transfection in comparison to cell
line, as reported by other authors (Krichevsky and Kosik, 2002), we still chose this
technique for our studies since we wanted to observe whether ablating En-1
expression in En2-/- ventral midbrain culture, which are viable in respect to the mDA
neurons, would impair mDA neuron survival. Our RNAi experiments showed that the
silencing effect occurred from 12 hour post-transfection (p.t.) until 4 days p.t. with a
maximum silencing effect at 48 hours. This is in line with other RNAi studies where
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half-life time of a protein is estimated around 40 hours (Jackson et al., 2003). The first
morphological signs of apoptotic cell death and the primary cell loss were observed
24 hours after the application of the siEn-1 oligos, this time course resembles the
disappearance rate of the midbrain dopaminergic neurons in the En-1 -/-, En-2-/-
embryos, and a similar time scale is also observed in 6-OHDA and MPTP induced
degeneration of the nigrostriatal DA system (Sundstrom et al., 1988; Jeon et al., 1995;
Zuch et al., 2000), and in hippocampal neurons after activation of the neurotrophin of
the low affinity neurotrophin,“ death receptor”,  receptor p75 (p75NTR) (Friedman,
2000). Each of these experimental models leads to the apoptosis activation within 24-
48hr, leading to damage of mitochondria and to the release of cytochrome c,
activation of the effector caspase-3 and eventually to cell death (Dobrowsky and
Carter, 2000; Vila and Przedborski, 2003). This suggests that the lack of En triggers
cell death following the common mitochondrial molecular pathway. The apoptotic
loss of mDA neurons in En double mutant mice, as early as E14, and the speed with
which apoptosis is induced in mDA neurons after silencing of En expression,
recapitulates the characteristic feature encountered in other PD models. It is feasible
therefore to assume that neuronal degeneration observed in PD patients, and the
dopaminergic neuronal loss in the En double mutants, may have a common molecular
origin. In the En double mutant, large alterations in the level of gene expression
downstream of En-1 and En-2 are probably the reason for the death of mDA neurons.
The fact that in the En-1 -/- En-2-/- a-synuclein is ablated (Simon et al., 2001) lead us
to speculate that indeed this molecule among others, which are yet unraveled, is
essential for the full maturation and viability of the mDA neurons. Differential
Microarray analysis of E12 and E14 En-1 -/-, En-2-/- and control littermate ventral
midbrain is currently in progress aiming to unravel the target genes of En, and cast
light on the essential molecular components for the maturation and survival of mDA
neurons. Moreover, in order to identify the molecular pathway leading to cell death in
the En-1 -/-, En-2-/- it will be necessary to track the key components of the apoptotic
cascade, according to present knowledge of the two principle apoptotic molecular
pathway and its components, and define the molecules involved in the PCD following
ablation of En expression. Once the molecules of the apoptotic pathway are identified,
we could try to interfere with the cell death program by targeting the same molecules
within the pathway. If the mDA neurons cell death occurs via the mitochondrial
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pathway, as it is often the case for the dopaminergic neurons, we could then plan to
rescue the En-1 -/-, En-2-/- mDA neurons by genetically targeting key molecules in
this pathway. Since there is already evidence that Bax-/- (Vila et al., 2001), p53-/-
(Trimmer et al., 1996) and Bcl-2 overexpressing mice (Yang et al., 1998) show a high
resistance to MPTP intoxication. By knocking out pro-apoptotic key molecules, Bax,
p53 or over-expressing antiapoptotic factors such as Bcl-2 first in 129 backcrossed
En-1 -/-, En-2-/- stem cells and then differentiate them into dopaminergic neurons, we
may rescue the En-1 -/-, En-2-/- phenotype.
V. En-1 acts as repressor for p75NTR expression.
Preliminary gene expression analysis of En1 over-expressing cell lines, obtained in
my laboratory, suggested that two key molecules involved in the apoptotic pathway
are regulated by the En genes, namely p53 and p75. p53 is an important pro-apoptotic
protein, which rapidly senses cell damage and induce an apoptotic program as after
MPTP intoxication (Mandir et al., 2002). Moreover p53 protein appears necessary for
complete expression of MPTP neurotoxicity to dopamine neurons as p53-/- null mice
result partially resistant to MPTP intoxication (Trimmer et al., 1996). MPTP
treatment, on the other side, leads to a cell death which proceeds at a rate similar to
the death of the mDA neurons in the En-1-/-, En2-/- mice. Additionally in both
systems, cell death occurs by apoptosis, suggesting that p53 may have been a
potential target of engrailed regulation and its derepression in absence of En, could
trigger apoptosis. The other molecule of interest was p75, the low affinity receptor for
the neurotrophin NGF, BDNF, and NT-3. This receptor is member of the TNF
receptor family as it shares with the other receptors an intracellular death domain and
it is widely expressed during development (Yan and Johnson, 1988). Among its
classical function in assisting the response of Trk proteins to their ligands (Barrett,
2000), it can promote an apoptotic signal depending on the different developmental
stages of sensory neurons (Barrett and Bartlett, 1994).  Upon neurotrophin treatment
and in absence or low expression of Trk receptors, it can mediate an apoptotic signal,
in different system such as glial cell (Casaccia-Bonnefil et al., 1996), a variety of
neuronal cell lines (Rabizadeh et al., 1994) and hippocampal neurons (Friedman,
2000). Moreover, BDNF is an important neurotrophic factor for mDA neurons during
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development (Hyman et al., 1991). This led us to speculate that the two neurotrophin
receptors could play an essential role in the development of the midbrain
dopaminergic neurons. To reinforce our hypothesis there is evidence that p75 can
transduce constitutively and rather rapidly (8hr) an apoptotic signal in sympathetic
neurons (Freidin, 2001), which is closely matching the death time course of the mDA
neurons in the En double mutant and in the RNAi experiments. From our quantitative
expression analysis of En-1 overexpressing cell line relatively to the non induced
control and the ventral midbrain of En-1 -/-, En-2-/- developmental, stage E12.5
(when the mDA neurons are present) relatively to the control littermate, it appeared
that p53 remained unchanged in all cases. In turn p75NTR was dramatically
downregulated in the En-1 overexpressing lines in comparison to the control, whereas
we measured a three fold expression increase in En-1 -/-, En-2-/- ventral midbrain in
respect to the littermate control. This suggests that indeed p75 signaling may be
involved in neuronal demise observed in the En-1 -/-, En-2-/-, by overcoming the
survival effect mediated by the Trk proteins (Persson and Ibanez, 1993; Birling and
Price, 1995). In addition the evidence that p75 juxtamembrane domain senses
alteration to membrane components after oxidative stress and cell damage thereby
triggering apoptosis (Hannun, 1996; Dobrowsky and Carter, 2000). Together with the
result emerging from the comparative differential display carried out in our
laboratory, which shows that one of the target gene of En is hydroxysteroid (17-b)
dehydrogenase-12, an intermediate enzyme involved in sphyngolipid synthesis, it is
suggestive that in En double mutant alteration to the cellular membrane structure may
activate p75 receptor, causing eventually cell death. In addition, analysis of the
promoter region for p75 confirmed that there are two highly matching consensus
sequences between –140-180bp and  –250-340bp from the start codon for the
Drosophila and mammalian En respectively. This speaks for a direct negative
regulation by the transcription factor on p75 expression, which is in line with the
“classical” role of engrailed as expression repressor (Araki and Nakamura, 1999;
Siegler and Jia, 1999) and strongly suggested p75 as good candidate in the
programmed cell death occurring in the En-1 -/-, En-2-/- mDA neurons.
To confirm our hypothesis regarding the involvement of p75 in the demise of the
mDA neurons we need to restrict our analysis only to the mDA neurons. To do so, we
are going to compare the pattern of expression of the En-1 -/-, En-2-/- ventral
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midbrain at E12.5 with that at E14.5. Since the two stages differ only for the presence
of the dopaminergic population, a subtractive analysis of the E12.5 on the E14.5 gene
expression pattern may cast light on genes, which are differentially expressed in the
midbrain dopaminergic neurons of the two phenotypes. Additionally, in order to
confirm that in our system the apoptotic signal is indeed mediated by p75 signaling,
we could try to block this signalling cascade by using antibodies against p75 that have
been previously applied to culture of sensory neurons of the trigeminal mesencephalic
nucleus and have resulted effective in preventing neurotrophin induced apoptosis
(Davey and Davies, 1998).
VII. En-1 has no direct influence on dopaminergic progenitors
In the En-1 -/-, En-2-/- mutant mice, mDA neurons are induced in a smaller domain at
E12.5 in comparison to the wild type this implies multiple scenarios:
I. En has a direct effect on the precursor cells, and the lack of these transcription
factors restricts the competent tissue that can form dopaminergic neurons. II. The lack
of En affects the survival of the mDA neurons, as it is demonstrated by our previous
experiments, reducing the life span of these neurons to 24-48 hr. The first DA neurons
are induced in the midbrain at E10.5 (Perrone-Capano and Di Porzio, 2000),
according to short life span of these neurons, what we see at around E12.5 is a
subpopulation of mDA neurons which has just completed the last cell cycle, whereas
the older neurons have already been committed to death. III. The consistent loss of
midbrain tissue in the En-1 -/-, En-2-/- mouse affects the isthmic region where Fgf-8
is expressed at the embryonic mid/hindbrain junction. This may impair the synergistic
inductive effect of Fgf-8 and Shh on the precursor cells of the mDA neurons. In order
to answer these questions we planned a gain of function experiment by over-
expressing the mouse En-1 in chick. We wanted to investigate the effect of En-1
misexpression on the induction of mDA neurons. Previously, Dittrich et al., 1997,
have performed over-expression of eagle in Drosophila in order to find out whether
the gene is required at the level of progenitors cells or at the level of the mature cells
in the specification of the serotoninergic neurons. Similarly Araki and Nakamura,
1999, over-expressed chick En-1 in the chick embryo at stage HH 10, at a time when
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En is responsible for the patterning of the mesencephalon. The authors observed that
misexpression of En  in the diencephalon induced an enlargement of the
mesencephalic tissue with rostral shift of the di-mesencephalic boundary and an
ectopic tectum. The midbrain-patterning function of En gene has been explained by
the direct repressing activity of this transcription factor on diencephalon-related
genes, such as Pax-6, and indirect inducing activity mesencephalon-related genes
such as Wnt-1, Fgf8, Pax-2, and Pax-8.  In Previous studies a replication competent
retroviral vector RCASBP(A)(Hughes et al., 1987) containing a mouse En-1 cDNA
was used to infect the chick neural tube at HH 8-10. Also in this case En
misexpression produced a pronounced caudal variation of the cytoarchitecture of the
rostral optic tectum, and rostral shift in the distribution of Eph-related receptor
kinases, RAGS and ELF-1, which are normally expressed in a decreasing gradient P
to A, reflecting the early En patterning (Logan et al., 1996). Those results indicate
that En is responsible for the patterning and identity of the mesencephalon. Taking
advantage of the regionalization function of En-1 we wanted to understand whether
an enlargement of the mesencephalic tissue, by En-1 overexpression, could expand
the mesencephalic competent tissue. In our over-expression experiments, where chick
embryos were electroporated with non-competent retroviral vector encoding for the
mouse En-1, we observed no effect on the number of mDA neurons at the midbrain.
The present results offers different explanations i) overexpression of En-1 alone does
not have any effect on the mesencephalic dopaminergic precursors, since at this stage
(HH8-10) it is responsible only for the regionalization of the mesencephalic tissue,
and only later it is required for the survival of the mDA neurons. Nevertheless, it
remains possible that En-1 and En-2 are both required for the specification of mDA
neurons, since it has been demonstrated that just one En-2 allele is able to maintain a
subpopulation of mDA neurons alive (Simon et al., 2001). To investigate this
possibility it would be necessary to perform simultaneous overexpression of both En-
1 and En-2 ii) inductive additional signals to Fgf-8 and Shh, such as Fgf-17 (Liu and
Joyner, 2001a), which are independent of En  expression may be involved in
commitment of the dopaminergic progenitors. Considering, also, that in the En-1-/-,
En-2-/- the mDA neurons are still being induced (Simon et al., 2001), despite the
consistent loss of the isthmic Fgf-8 domain (Liu and Joyner, 2001b). Thus
enlargement of the Fgf-8 domain due to En overexpression would not be enough to
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commit more progenitor cells to a dopaminergic fate. To further investigate this issue
it may be interesting to analyze the pattern of expression of other Fgf family members
in the En-1-/-, En-2-/-, and prove their inducing effect on neural stem cells (NSC) in
culture. Finally iii) the developmental window when the overexpression is performed
may be postum to an early specification of the midbrain dopaminergic precursor.
Thereby the lack of inductive effect would be restricted to an experimental question
and further electroporation experiment previous to HH 8 are planned in future to solve
this issue.
Another interesting experiment would be to co-express En-1 with other intracellular
mediator to observe any change in the induction of the mDA neurons.  Lmx-1b is a
good candidate since it shares features of the engrailed genes and it is also involved in
MHB regionalization (Adams et al., 2000) and it is expressed before the mDA
neurons are being induced (Smidt et al., 2000). In addition, similarly to the En-1 -/-,
En-2-/- mouse mutant, in the Lmx-1b-/- mDA neurons are induced in a smaller
domain (Smidt et al., 2000). This phenotypical homology between the two
transcription factors raises the interesting question whether the two transcription
factors could co-operate in the specification of the dopaminergic phenotype at
progenitor level.
 Conclusions
The outcomes of this study show that i) En genes are progressively expressed in the
mDA neurons from E12 on ii) E n genes are cell autonomous required for the
maturation and survival of mDA neurons. Lack of En expression leads to apoptotic
cell death. iii) En doesn’t regulate axonal outgrowth of the mDA neurons neither by
regulating cytoskeletal organization, nor by modulating expression of the adhesion
molecule L-1 on the mDA neurons. iv) En-1 function as transcriptional repressor of
p75 expression and it is a good candidate for the death signaling which leads to the
rapid demise of the mDA neurons. v) En-1 does not specify the midbrain precursors
cells to their final dopaminergic phenotype
A major challenge will be to find out in more detail the target genes of En in the mDA
neurons and understand how those molecules are involved in the full maturation of
the mDA neurons. In addition unraveling components involved in the apoptotic
cascade that mediates cell death in the En-1 -/-, En-2-/- mDA neurons will be useful
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to perform gain of function experiment in order to rescue En-1 -/-, En-2-/- mDA
neurons.
This work suggests that En is a fundamental component of the mDA neurons, further
studies also on human could help to understand if En can be one of the gene involved
in the etiology of PD.
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